<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/177808</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;177808v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;177808</article-id><article-id pub-id-type="other" hwp:sub-type="slug">177808</article-id><article-id pub-id-type="other" hwp:sub-type="tag">177808</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Microbiology" hwp:journal="biorxiv"><subject>Microbiology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Characteristics of a Block to Entry via an HIV-2 Envelope, MCR</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label>Corresponding author: <email hwp:id="email-1">rebmerg@ucl.ac.uk</email>. Current address: London Centre for Nanotechnology, University College London, 17-19 Gordon St, London WC1H 0AH</corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6515-839X</contrib-id><name name-style="western" hwp:sortable="Gray Eleanor R."><surname>Gray</surname><given-names>Eleanor R.</given-names></name><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-6515-839X"/></contrib><aff id="a1" hwp:id="aff-1"><institution hwp:id="institution-1">Division of Virology, National Institute for Medical Research, Mill Hill</institution>, London NW7 1AA, <country>UK</country>
</aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2017"><year>2017</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2017-08-17T15:18:48-07:00">
    <day>17</day><month>8</month><year>2017</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2017-08-17T15:18:48-07:00">
    <day>17</day><month>8</month><year>2017</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2017-08-17T15:43:55-07:00">
    <day>17</day><month>8</month><year>2017</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2017-08-17T15:43:55-07:00">
    <day>17</day><month>8</month><year>2017</year>
  </pub-date><elocation-id>177808</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2017-08-17"><day>17</day><month>8</month><year>2017</year></date>
<date date-type="rev-recd" hwp:start="2017-08-17"><day>17</day><month>8</month><year>2017</year></date>
<date date-type="accepted" hwp:start="2017-08-17"><day>17</day><month>8</month><year>2017</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2017</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/" hwp:id="license-1"><p hwp:id="p-1">This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="177808.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/177808v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="177808.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/177808v1/177808v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/177808v1/177808v1.htslp"/><abstract hwp:id="abstract-1"><p hwp:id="p-2">Successful viral infection depends not only on targeting the correct cell type, but also on the route taken into the cell. After entry, a retrovirus must reverse transcribe its genome and access the nucleus. Blocks to infection can arise at many different stages of the cycle; if they occur only in some cell types it can reveal hitherto unknown aspects of viral or cellular biology. A block to infection of a primary isolate of HIV-2 was previously identified in specific cell types. In this study, parameters of route of entry of the envelope protein from this primary isolate, MCR, were investigated. A critical component of the block acts at a pre-reverse transcription stage, as virions pseudotyped with MCR envelope did not undergo fusion and entry rates commensurate with productive infection. Furthermore, expression of p56<sup>lck</sup>, which regulates CD4 surface expression, partially rescued infection of MCR envelope-pseudotyped virus in restrictive cell types. Based on these findings, we propose that a part of this block results from poor cell-surface expression of CD4.</p></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-1">Keywords</title><kwd hwp:id="kwd-1">HIV</kwd><kwd hwp:id="kwd-2">entry block</kwd><kwd hwp:id="kwd-3">Lv2</kwd><kwd hwp:id="kwd-4">p56<sup>lck</sup></kwd><kwd hwp:id="kwd-5">fusion</kwd></kwd-group><counts><page-count count="15"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2"><sc>Introduction</sc></title><p hwp:id="p-3">Innate blocks to retroviral infection of mouse cells were described over 50 years ago (<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">Lilly, 1970</xref>, <xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">Friend, 1957a</xref>,b). In 2000, a capsid (CA)dependent block in other mammalian cell lines was described (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">Towers et al., 2000</xref>) and Trim5<italic toggle="yes">α</italic> was identified in 2004 (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">Stremlau et al., 2004</xref>). Primate variants of Trim5<italic toggle="yes">α</italic> are the causal agent of both HIV-1 restriction in rhesus macaques (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-2" hwp:rel-id="ref-57">Stremlau et al., 2004</xref>) and N-MLV restriction in primate cell lines (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">Keckesova et al., 2004</xref>, <xref ref-type="bibr" rid="c65" hwp:id="xref-ref-65-1" hwp:rel-id="ref-65">Yap et al., 2004</xref>). Cells resistant to infection under certain circumstances have been discovered both by serendipity and rigorous screens, and this has led to the discovery of novel genes that induce resistance (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">Gao and Goff, 1999</xref>, <xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">Bruce et al., 2005</xref>, <xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">Pineda et al., 2007</xref>). Evidence of protective functions of Trims other than Trim5<italic toggle="yes">α</italic> (<xref ref-type="bibr" rid="c65" hwp:id="xref-ref-65-2" hwp:rel-id="ref-65">Yap et al., 2004</xref>) has been investigated, as well as variants of Trim5<italic toggle="yes">α</italic> itself in which CypA replaces the B30.2 region (<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">Sayah et al., 2004</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">Newman et al., 2008</xref>, <xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">Wilson et al., 2008</xref>).</p><p hwp:id="p-4">In 2004 a block to replication of HIV-2 by a restriction factor-like agent was described with both capsid (CA) and envelope (Env) dependent components (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>), and this block was named Lv2. Lv2 is dependent on CA sequence, with an additional Env component that can be overcome by pseudotyping with VSV-G. This suggested a route of entry dependence (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-2" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>, <xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">Marchant et al., 2005</xref>). Lv2 was characterised in four cell types; HeLa CD4 cells (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">Scherer et al., 1953</xref>, <xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">Maddon et al., 1986</xref>) and Ghost/CXCR4 (<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">Cecilia et al., 1998</xref>) restrict Lv2-susceptible viruses, whereas NP2/CD4/CXCR4 (NP2) (<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">Soda et al., 1999</xref>) and U87/CD4/CXCR4 (U87) (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">Björndal et al., 1997</xref>) do not. Lv2 was initially identified with a primary isolate (prCBL-23) and a T-cell line adapted isolate (CBL-23) of HIV-2, but studies were continued using their equivalent molecular clones, known as MCR and MCN, molecular clone restricted (Lv2 sensitive) and non-restricted (Lv2 insensitive), respectively (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-3" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>). These names refer to the whole virus clone of Env and Gag-pol.</p><p hwp:id="p-5">The different contributions of Env and CA to Lv2 were described by exchange of MCR and MCN Env with their cognate Gag-pol (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-4" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">Reuter et al., 2005</xref>). Virions composed of MCR Gag-pol and Env replicated to over 50-fold higher titres on U87 cells compared to restrictive cells (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-5" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-2" hwp:rel-id="ref-49">Reuter et al., 2005</xref>), whereas pseudotyping with MCR Env pseudotypes conferred 20-fold restriction on non-susceptible Gag (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-6" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>). An additional restriction to infection (of 19- or 5-fold (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-7" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-3" hwp:rel-id="ref-49">Reuter et al., 2005</xref>)) in HeLa CD4 cells compared to U87 cells was attributable to Gag. Thus Env and Gag act in concert to determine the extent of virus restriction. The determinant in Gag is in CA, at position 207 where there is an isoleucine (MCR) or valine (MCN) (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-8" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>). The Env determinant was mapped to position 74 in SU; glutamic acid (E) for MCR or glycine (G) for MCN (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-4" hwp:rel-id="ref-49">Reuter et al., 2005</xref>). Lv2 affects HIV-1 cores equivalently to HIV-2 (<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-2" hwp:rel-id="ref-30">Marchant et al., 2005</xref>, <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">Harrison and McKnight, 2011</xref>), showing that Env is a key determinant and can confer sensitivity on an unrelated core. VSV-G pseudotypes of MCR Gag are fully infectious, thus entry via an endocytic route to both Lv2-negative and Lv2-positive cells appears to subvert the block to infection (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-9" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>).</p><p hwp:id="p-6">If the block to MCR Env-pseudotyped virus is post-entry and route-dependent, then the novel nature of the block is of interest, and could reveal routes of viral entry, and hitherto unknown facets of intracellular compartments. In these studies we describe work to show that conclusive evidence of fusion and entry of restricted virus was not found, hypothesising that the primary cause of the block to infectivity to MCR Env-pseudotyped virus lies in differences in cell biology between restrictive and non-restrictive cells. The cellular basis of the block to MCR Env-pseudotyped virus in HeLa CD4 cells is unlikely to lie within a traditional definition of a restriction factor.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-3"><sc>Methods</sc></title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-4">Cells and Viruses</title><p hwp:id="p-7">293T, Mus dunni, HeLa CD4 (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-2" hwp:rel-id="ref-52">Scherer et al., 1953</xref>), NP2/CD4/CXCR4 (NP2) (<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-2" hwp:rel-id="ref-54">Soda et al., 1999</xref>) and U87/CD4/CXCR4 (U87) (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">Björndal et al., 1997</xref>) cells were cultivated in DMEM supplemented with 5% (except 293T and Mus dunni, 10%) foetal calf serum and antibiotics. HeLa CD4, NP2 and U87 cells were gifts from Professor Áine McKnight (Queen Mary, University of London). 'Tester' viruses were generated essentially as described in (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">Bock et al., 2000</xref>) with 7<italic toggle="yes">μ</italic>g of the following vectors using a calcium phosphate-based transfection method (Promega): HIV-1 virus-like particles (VLPs) CSGW (<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">Bainbridge et al., 2001</xref>) and p8.91 (<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">Naldini et al., 1996</xref>); HIV-2 VLPs HIV2 and HIV-2pack (<xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">Ylinen et al., 2005</xref>); SIV3+ (<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">Besnier et al., 2002</xref>); Envelope vectors were MCR (a gift from Professor Áine McKnight), p456 (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">Soneoka et al., 1995</xref>) or pczVSV-G (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">Bock et al., 2000</xref>) to produce MCR-, amphotropicor VSV-G-pseudotyped VLPs. If S15-mCherry (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">Campbell et al., 2007</xref>) and GFP-Vpr (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">McDonald et al., 2002</xref>) were included, 5<italic toggle="yes">μ</italic>g each of CSGW, p8.91, VSV-G or MCR, and GFP-Vpr were used with 0.5<italic toggle="yes">μ</italic>g S5-mCherry. For generation of p56<sup><italic toggle="yes">lck</italic></sup> vector, the cDNA was obtained from the IMAGE Consortium (<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">Lennon et al., 1996</xref>) and cloned into the gateway vector pLgatewayIRESYFP (<xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">Yap et al., 2007</xref>), and used with pHIT60 (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-2" hwp:rel-id="ref-55">Soneoka et al., 1995</xref>) and pczVSVG. 18h post-transfection, cells were treated with 10mM sodium butyrate for 6 h. 48 h after transfection, virus was harvested, filtered through a 0.45<italic toggle="yes">μ</italic>m filter, and stored immediately at −80<italic toggle="yes">°</italic> C. Viral stocks were titrated on Mus dunni cells if pseudotyped with VSV-G or amphotropic envelope, or on NP2 cells if MCR Env. 5<italic toggle="yes">×</italic>10<sup>4</sup> cells were plated and allowed to settle. 24 hours later, 250-500<italic toggle="yes">μ</italic>l virus stock was added to a well in a total volume of 500<italic toggle="yes">μ</italic>l, and serial 1:5 dilutions made for at least 8 wells. 24 hours later the media was refreshed, and after a further 48 hours titres were assessed by FACS. All viruses used were HIV-1 based, unless specifically stated otherwise.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-5">Restriction Assays</title><p hwp:id="p-8">Single colour assays for entry and a single round of infection were carried out as described previously (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-3" hwp:rel-id="ref-7">Bock et al., 2000</xref>). Briefly, 5<italic toggle="yes">×</italic>10<sup>4</sup> cells were seeded in 12-well plates, challenged after 16hrs with MOI 0.001 to 10 VSV-G, amphotropic MLV envelope (ampho), or MCR Env-pseudotyped virus. 48hrs later, cells were harvested, fixed in phosphate-buffered saline (PBS)-3.5% formalin, and titres assessed by FACS (BD LSRII, default filter set). Dual colour (YFP/GFP) assays for entry and a single round of infection for cells transduced with delivery vector encoding p56<sup><italic toggle="yes">lck</italic></sup> and eYFP were carried out as described previously (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">Ohkura et al., 2011</xref>). Briefly, 5<italic toggle="yes">×</italic>10<sup>4</sup> cells were seeded in 12-well plates and transduced after 16hrs with MOI 1 p56<sup><italic toggle="yes">lck</italic></sup> vector. After a further 48hrs, cells were trypsinized and reseeded at 1:6 (NP2/U87) or 1:12 (HeLa CD4), then challenged after 16hrs with tester virus. 48hrs later, cells were harvested, fixed in PBS-3.5% formalin, and titres assessed by FACS (BD LSRII with YFP/GFP filter set, namely 550/30 and 525LP for YFP, 510/20 and 505LP for GFP).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-6">Quantitative PCR</title><p hwp:id="p-9">Extraction, quantitation, amplification and normalization were performed essentially as described in (<xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">Yap et al., 2006</xref>). Briefly, 2<italic toggle="yes">×</italic>10<sup>5</sup> cells were plated, and 24 hours later incubated with virus at MOI of 2-5 for 6 or 18 hours. Total DNA was extracted with the QIAamp DNA kit (Qiagen). HIV-1 early reverse transcription products were detected using primers HIVEF and HIVER (<xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-2" hwp:rel-id="ref-64">Yap et al., 2006</xref>).</p></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-7">Microscopy and Particle Counting</title><p hwp:id="p-10">Microscopy was performed essentially as described in (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">Mortuza et al., 2008</xref>) with the following specific constraints for sample preparation. Cells were plated on glass coverslips in a 12-well dish at 1<italic toggle="yes">×</italic>10<sup>5</sup> cells/well, and infected 16 hours later at 4<italic toggle="yes">°</italic> C with virus at MOI 5. Cells were spinoculated at 15<italic toggle="yes">°</italic> C and 1200<italic toggle="yes">×</italic>g for 2 hours, then 1ml pre-warmed DMEM ±40mM NH<sub>4</sub> Cl was added to each well, and infection allowed to proceed at 37<italic toggle="yes">°</italic> C for 2hrs. To end infection, cells were washed 1 <italic toggle="yes">×</italic> with PBS and incubated with 4% paraformaldehyde in PBS at room temperature for 15 minutes. Slides were viewed on a Deltavision Olympus IX70 inverted microscope with 100x lens and initially analysed using Softworx image acquisition software (Applied Precision). Where necessary, images were further viewed using Adobe Photoshop CS2 (Adobe Systems) which permits removal of each red/green/blue channel individually. For counting of virions, pictures were randomised and renamed by a third party, then scored blind for the extent of overlay of green and red fluorescence.</p></sec></sec><sec id="s3" hwp:id="sec-7"><title hwp:id="title-8"><sc>Results</sc></title><sec id="s3a" hwp:id="sec-8"><title hwp:id="title-9">HeLa CD4 and NP2 cells are equally permissive to a selection of HIV-1, HIV-2 and SIV cores pseudotyped with VSV-G</title><p hwp:id="p-11">HIV-1, HIV-2 and SIV viral cores were pseudotyped with VSV-G or MCR Env to assess the permissivity of HeLa CD4 and NP2 cells. The HIV-2 vector, derived from ROD10, has an MCR-type isoleucine at Gag 207. Titres of VSVG pseudotyped virus were equivalent for all cores on both cell types (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figure 1a</xref>-c). Titres of MCR Env-pseudotyped virus were equally high on NP2 cells, but on HeLa CD4 cells titres were 10 to 100-fold lower. This confirms the route of entry dependence of the Lv2-phenotype, in that the same core pseudotyped with different envelope proteins can exhibit different levels of infectivity.</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;177808v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1:</label><caption hwp:id="caption-1"><p hwp:id="p-12">Virus pseudotyped with MCR Env does not successfully replicate on HeLa CD4 cells, but does on NP2 cells. NP2 and HeLa CD4 cells were transduced with MCR and VSV-G pseudotyped a) HIV-1, b) HIV-2 and c) SIVmac cores, and analysed 3 days later by FACS. Viral titres were equivalent for NP2 cells, but MCR Envpseudotyped virus titres were reduced 10- to 100-fold on HeLa CD4 cells. Shown are the combined results from 3 independent experiments. d) HIV-1 cores pseudotyped with NL4-3 envelope are not able to replicate to high titres on HeLa CD4 cells. Cells were infected with NL4-3pseudotyped HIV-1 core at MOI 0.02 to 2, and analysed 3 days later by FACS. Shown are the combined results of four independent experiments for both cell types, and error bars represent the standard deviation of the mean.</p></caption><graphic xlink:href="177808_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-13">MCR and MCN bind to CD4 and CXCR4 (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">McKnight et al., 2001</xref>). Pseudotyping virions with MCN Env did not circumvent the block to infection seen in HeLa CD4 cells with a considerable 10-100-fold restriction compared to NP2 or U87 cells (Supplementary Figure 1). As MCN Env-pseudotyped virions were thus significantly restricted on HeLa CD4 cells, this could not be used as a control for further experiments. To assess whether another, different CD4/CXCR4-tropic envelope also renders the virus susceptible to this block to infection, NL4-3 Env was used. <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Figure 1d</xref> shows that for all input titres of NL4-3 Env-pseudotyped virus, NP2 cells are between 10to 100-fold more permissive compared to HeLa CD4 cells. The difference was greatest at lower viral titres. Therefore the block to infectivity is not unique to MCR Env, but also affects MCN Env and at least one other CD4/CXCR4-tropic envelope.</p></sec><sec id="s3b" hwp:id="sec-9"><title hwp:id="title-10">Reduced levels of reverse transcription products are seen in HeLa CD4 cells infected with MCR pseudotyped virus, compared to NP2 cells</title><p hwp:id="p-14">Analysis of the first products of reverse transcription reveals whether the virus can enter the cell and reverse transcribe. <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Figure 2a</xref> shows a comparison of relative strong stop transcript levels at 6 and 18hrs of MCR and VSV-G pseudotyped virus on HeLa CD4 cells. Levels of MCR transcripts reach 21% of those of VSV-G (which is set to 100%) at both 6 and 18hr timepoints. <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figure 2b</xref> shows the level of reverse transcription products in HeLa CD4 and NP2 cells after infection with VSV-G or MCR pseudotyped virus at 18hrs. Infection by virions pseudotyped with these two envelopes produced equivalent levels of strong-stop transcripts in NP2 cells, but not HeLa CD4 cells. For virions pseudotyped with MCR Env, levels of strong stop transcripts in HeLa CD4 cells were 24% of those obtained from an infection with VSV-G pseudotyped virus. These data show that the accumulation of appreciable levels of strong stop transcripts does not occur in HeLaCD4 cells for viruses pseudotyped with MCR Env.</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;177808v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2:</label><caption hwp:id="caption-2"><p hwp:id="p-15">Reverse transcription product levels from HeLa CD4 and NP2 cells infected with virus pseudotyped with VSV-G or MCR Env. Cells were plated out, and 24 hrs later were incubated with virions at MOI 0.8 to 1 at 4° C for 1 hour to permit binding. Infection was initiated by addition of pre-warmed medium, and transfer to 37° C. a) After 6 or 18 hrs cells were harvested, and DNA extracted from HeLa CD4 cells alone. Levels of early products of reverse transcription were assessed by qPCR, and the levels of DNA normalized using actin. Results shown are combined from four independent experiments. b) After 18 hrs cells were harvested and DNA extracted from HeLa CD4 and NP2 cells, levels of early reverse transcription products were again assessed by qPCR and normalized to actin. The level of reverse transcription products for VSVG-pseudotyped viruses is set to 100%. VSV-G data shown in white, and MCR data in grey bars. Results shown are combined from four independent experiments, and error bars represent the standard deviation of the mean.</p></caption><graphic xlink:href="177808_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-16">Two examples of a pre-reverse transcription block caused by a restriction factor are Trim5<italic toggle="yes">α</italic> and Trim5Cyp (<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">Nisole et al., 2004</xref>, <xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-3" hwp:rel-id="ref-57">Stremlau et al., 2004</xref>). Infection of Trim5<italic toggle="yes">α</italic> or Trim5Cyppositive cells with susceptible virus leads to a drop in reverse transcription intermediates that varies between 5 and 10-fold (<xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-3" hwp:rel-id="ref-64">Yap et al., 2006</xref>, <xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-2" hwp:rel-id="ref-66">2007</xref>, <xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-4" hwp:rel-id="ref-57">Stremlau et al., 2004</xref>, <xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">Fletcher et al., 2010</xref>, <xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">Anderson et al., 2006</xref>) (although the difference in infectivity caused by these blocks can be greater than 10-fold) so the drop seen here is commensurate with the lack of significant synthesis of reverse transcription products as seen for other restriction factors.</p><p hwp:id="p-17">These results are also comparable to previous studies comparing levels of reverse transcripts by virions pseudotyped with MCR Env produced from HeLa CD4 and unrestrictive cells. The original primary isolate later cloned as MCR, prCBL23, produced higher levels of LTR-gag on U87 cells compared to HeLa CD4 cells (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-2" hwp:rel-id="ref-33">McKnight et al., 2001</xref>). Schmitz et al. found ratios of strong-stop reverse transcripts for MCR pseudotyped virions were between 7-25-fold higher from U87 cells compared to HeLa CD4 cells at timepoints between 1 and 18hrs (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-10" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>). Marchant et al. also reported greatly reduced levels of reverse transcripts from HeLa CD4 cells compared to U87 cells from MCR Env pseudotyped virus at 2 and 6hrs, though by 18hrs the levels had equalised (<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-3" hwp:rel-id="ref-30">Marchant et al., 2005</xref>). This suggests that MCR Env-pseudotyped virions are unable to produce levels of reverse transcripts in HeLa CD4 cells that are sufficient for a productive infection.</p></sec><sec id="s3c" hwp:id="sec-10"><title hwp:id="title-11">The block to infection in HeLa CD4 cells cannot be abrogated</title><p hwp:id="p-18">To assess whether the block to MCR-pseudotyped virions can be saturated, in common with Fv1 and Trim5<italic toggle="yes">α</italic>, the susceptibility of the block to abrogation was assessed, as shown in Supplementary Figure 2. No increase in titres was seen when a prior, restricted dose of virus was applied, indicating that the block to infection cannot be saturated (compare to <xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">Towers et al. (2002)</xref>, <xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">Dodding et al. (2005)</xref>). This means that the block to infection is dissimilar in nature to saturable restriction factors such as Fv1 and Trim5<italic toggle="yes">α</italic>.</p></sec><sec id="s3d" hwp:id="sec-11"><title hwp:id="title-12">Levels of viral fusion can be monitored using virions produced in cells expressing s15mCherry</title><p hwp:id="p-19">MCR Env-pseudotyped virions exhibit lower infectivity on HeLa CD4 cells and do not reverse transcribe at equivalent levels to those on NP2 cells. Therefore the antecedent stage to investigate in the process was fusion, which must occur prior to reverse transcription. A fluorescent fusion protein comprised of mCherry and the 15 N-terminal amino acids of Src (s15-mC) coats nascent viral particles with a red membrane as they leave the producer cell (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">Rodgers, 2002</xref>, <xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">Campbell et al., 2007</xref>). The signal disperses and is lost after fusion between the viral and cellular membranes has taken place. If fusion is blocked then the red signal remains intact (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-3" hwp:rel-id="ref-10">Campbell et al., 2007</xref>). This system was used to analyse whether fusion was successfully taking place between MCR pseudotyped viruses and HeLa CD4 cells. To monitor virions after fusion, the fluorescent core protein GFP-Vpr was used (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-2" hwp:rel-id="ref-31">McDonald et al., 2002</xref>). Viral particles outside the cell, and those bound to cells pre-fusion remain both green and red; those that have successfully fused are green only.</p><p hwp:id="p-20">For proof of concept, GFP-vpr and s15-mCcontaining viral particles were pseudotyped with VSV-G envelope protein, bound to HeLa CD4 or U87 cells on coverslips and then incubated for two hours in the presence or absence of NH<sub>4</sub> Cl. This blocks initiation of fusion by the VSV-G envelope so that the virus remains trapped in endosomes (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">Aiken, 1997</xref>, <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">Brindley and Maury, 2005</xref>, <xref ref-type="bibr" rid="c58" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">Superti et al., 1987</xref>). After infection and fixation, at least 10 pictures were taken, randomised, and scored blind for overlapping red and green, or green alone, punctae. Examples of pictures used to obtain data are shown in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3a</xref>, and the percentage of green vs. green and red particles in each of the different conditions quantified in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Figure 3b</xref>.</p><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7 xref-fig-3-8"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;177808v1/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3:</label><caption hwp:id="caption-3"><p hwp:id="p-21">Virions pseudotyped with VSV-G or MCR Env visualised after binding to HeLa CD4, NP2 or U87 cells. Cells were infected with GFP-vpr/S15-mCherry virus pseudotyped with A+B) VSV-G in the presence or absence of NH4Cl, or C+D) MCR Env at MOI 1. Images in (a) and (c) are shown for RGB channels (i, iii and v) or R channel only (in greyscale, ii, iv and vi). a) i+ii) VSV-G pseudotyped virions used to infect cells, showing red and green fluorescence; a) iii to vi) HeLa CD4 cells and virions pseudodyped with VSV-G without (iii + iv) and with (v and vi) NH4Cl. c) virions pseudotyped with MCR Env and (i + ii) HeLa CD4 cells, (iii + iv) NP2 cells and (v + vi) U87 cells. A representative picture of at least 10 taken per condition is shown for (a) and (c). The boxes in (a)(v) and (c)(iii) show two identical enlarged views of the section enclosed by dashed lines, with the green channel removed for the second view to show an example of a fused and unfused virion in each case. The quantified results in (b) and (d) are the proportions of virions that have successfully fused with the cell, lost their red membrane signal and show GFP fluorescence only. Proportions per picture are shown, averaged from at least 10 separate pictures taken per condition, randomised, and over 500 virions per condition counted and scored blind for red or red and green fluorescence. All images were taken at the same scale. Error bars show standard deviation of the mean number of virions fused per picture. Results from one experiment are shown of two performed. *denotes p&lt; 0.05, NS=not significant (Student's t-test).</p></caption><graphic xlink:href="177808_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-22">The data in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Figure 3b</xref> show that after 2 hours of incubation with media alone, 62 and 59% of viral particles had undergone fusion in HeLa CD4 and U87 cells respectively. If NH<sub>4</sub> Cl was present, successful fusion events were seen in only 12% of particles tallied, for both cell types. Assured detection of the presence of a red label is harder than its absence, so the percentage of fusion events in cells could be even lower than these values. This method provides an alternative to qPCR to assess whether virions have entered cells, and permits assessment of the post-binding fusion of the viral and cellular membranes at a stage before reverse transcription.</p></sec><sec id="s3e" hwp:id="sec-12"><title hwp:id="title-13">Levels of fusion between HeLa CD4 cells and MCR pseudotyped HIV-1 are insufficient for infection</title><p hwp:id="p-23">The S15-mC and GFP-vpr labels were used to assess the proportion of MCR Env-pseudotyped viral particles that underwent fusion in HeLa CD4, NP2 and U87 cells. Two cell lines permissive to MCR were assessed to types. Sample pictures are shown in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Figure 3c</xref> and the quantified data in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Figure 3d</xref>.</p><p hwp:id="p-24">A significant difference in the proportion of virions fused was seen between either HeLa CD4 and U87 cells, or HeLa CD4 and NP2 cells. The proportion of MCR virions that underwent fusion per picture was 15%, 60%, and 75% for HeLa CD4, NP2 and U87 cells, respectively (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Figure 3d</xref>). Furthermore, the difference in fusion levels between HeLa CD4 cells with MCR pseudotyped virus, or HeLa CD4 cells with VSV-G pseudotyped virus held under an NH<sub>4</sub> Cl-induced block to infection was not significant. This indicates that the level of fusion is insufficient for a productive infection for both conditions.</p><p hwp:id="p-25">Interestingly, the average number of MCR virions per picture of HeLa CD4 cells was 21.5, which was lower than for VSV-G virions with HeLa CD4 cells (93.2), or MCR virions with NP2 cells (81.7) and U87 cells (46.2). This is an incidental observation, but could suggest that CD4 binding of MCR Env is easily disrupted, perhaps by the washing steps. Antibody binding studies by Reuter et al., however, showed that MCR Env actually conferred a ten-fold resistance to inhibition of infection by anti-CD4 antibody compared to unrestricted envelope (MCN), concluding that MCR binds to CD4 more tightly (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-5" hwp:rel-id="ref-49">Reuter et al., 2005</xref>). So it is more likely that MCR does not readily bind in the first place. Platt et al. suggest that the low affinities for CD4 seen for patient isolates envelopes generally may be an adaptation that allows them to bypass cells that would not result in a productive infection and have low levels of CD4 at the cells surface, such as early T cell progenitors (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">Platt et al., 2000</xref>). Alternatively, the turnover of virions by HeLa CD4 cells could be more rapid, with a higher rate of recycling of bound virus.</p><p hwp:id="p-26">These data, showing that MCR Envpseudotyped virions do not fuse with HeLa CD4 cells at levels sufficient for a productive infection, combined with the lack of products of reverse transcription and non-saturation of the block, would suggest that there could be a difference in presentation, signalling or regulation of these receptors in HeLa CD4 cells that is different to NP2 and U87 cells, and this possibility was next examined.</p></sec><sec id="s3f" hwp:id="sec-13"><title hwp:id="title-14">Expression of p56<sup><italic toggle="yes">lck</italic></sup> renders HeLa CD4 cells moderately permissive to MCR pseudotyped virions</title><p hwp:id="p-27">CD4 is a marker of differentiation found primarily on T cells, and control of CD4 levels at the cell surface is mediated by the tyrosine kinase p56<sup><italic toggle="yes">lck</italic></sup>, which is constitutively associated with the cytoplasmic domain, and plays a key role in regulating endocytosis (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">Pelchen-Matthews et al., 1991</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">1992</xref>, <xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">1995</xref>, <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">Pitcher et al., 1999</xref>). CD4 that has no cytoplasmic domain and cannot interact with p56<sup><italic toggle="yes">lck</italic></sup> is likewise constitutively endocytosed (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-2" hwp:rel-id="ref-42">Pelchen-Matthews et al., 1991</xref>, <xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-2" hwp:rel-id="ref-44">1995</xref>, <xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">Foti et al., 2002</xref>, <xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">Yousefi et al., 2003</xref>). HeLa cells are not thymocytes, and the presence or absence of regulatory mechanisms that control internalisation of CD4 is unknown, though differences in CD4 levels were previously shown to affect infectivity levels of primary and laboratoryadapted viruses (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">Kozak et al., 1997</xref>). Either extensive endocytosis of receptor-virus complex before initiation of fusion, low expression of CD4 at the cell surface, downstream signalling or unknown interactions could be affected by p56<sup><italic toggle="yes">lck</italic></sup>, all of which could influence infection by MCR, and this was therefore investigated further.</p><p hwp:id="p-28">HeLa CD4 cells were transduced with a vector expressing p56<sup><italic toggle="yes">lck</italic></sup> and yellow fluorescent protein (YFP) from an internal ribosome entry site (IRES). An immunoblot of p56<sup><italic toggle="yes">lck</italic></sup> and CD4 expression is shown in Supplementary Figure 3, and shows the absence of p56<sup><italic toggle="yes">lck</italic></sup> in untransduced HeLa CD4 and NP2 cells, good expression levels of p56<sup><italic toggle="yes">lck</italic></sup> in transduced cells, and good expression levels of total CD4 across all cells.</p><p hwp:id="p-29">The expression of CD4 and CXCR4 at the cell surface in cells with or without added p56<sup><italic toggle="yes">lck</italic></sup> expression was assessed by surface staining through FACS analysis (Supplementary Figure 4 and Supplementary Table 1). The baseline level of anti-CD4 binding to HeLa CD4 cells without the p56<sup><italic toggle="yes">lck</italic></sup> vector (YFP negative) was no different to unstained controls. A small but reproducible increase in levels of anti-CD4 signal was seen for HeLa CD4 cells expressing YFP (and by extension, p56<sup><italic toggle="yes">lck</italic></sup>). The significance of this small but persistent increase in median fluorescence intensity level seen on transition from baseline to GFP-negative cells to GFP-positive cells was ascertained by a simple one-tailed rank test. The probability that all experiments give the same ordering of values is p=0.016, meaning that the result is significant at the 95% level. For NP2 cells, p56<sup><italic toggle="yes">lck</italic></sup> /YFP expression made no difference to CD4 cell-surface levels. Additionally, CXCR4 levels for both HeLa CD4 and NP2 cells were not changed by p56<sup><italic toggle="yes">lck</italic></sup> expression, though levels in NP2 cells appeared to be markedly higher.</p><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;177808v1/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4:</label><caption hwp:id="caption-4"><p hwp:id="p-30">Expression of p56<sup><italic toggle="yes">lck</italic></sup> renders HeLa CD4 cells over ten times more susceptible to infection by MCR Envpseudotyped virus. Cells were plated and infected with p56<sup><italic toggle="yes">lck</italic></sup> vector at MOI 1-2. After three days, cells were replated and infected by MCR-pseudotyped HIV-1 at MOI 1-2. The extent of infection assayed three days later by FACS and compared to p56<sup><italic toggle="yes">lck</italic></sup>-positive and negative cells within the same well, as assessed by YFP fluorescence. Shown are the individual results of three experiments for HeLa CD4 cells, and two for NP2 cells.</p></caption><graphic xlink:href="177808_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-31">A mixed population of HeLa CD4 cells with and without the p56<sup><italic toggle="yes">lck</italic></sup> -YFP vector was then challenged with MCR pseudotyped virus, and the effects of p56<sup><italic toggle="yes">lck</italic></sup> on titres are shown in <xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Figure 4</xref>. The two cell lines were plated out together in wells so that a direct comparison could be done under identical conditions, as HeLa CD4 p56<sup><italic toggle="yes">lck</italic></sup> positive cells can be identified by YFP fluorescence. When p56<sup><italic toggle="yes">lck</italic></sup> is expressed in HeLa CD4 cells, titres of MCR ENV-pseudotyped virus increase from undetectable levels (under 1%) to on average around 10-fold higher (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Figure 4</xref>). Expression of p56<sup><italic toggle="yes">lck</italic></sup> in NP2 cells raised titres by less than two-fold, indicating that the effect of p56<sup><italic toggle="yes">lck</italic></sup> in HeLa CD4 cells is either reduced or absent in NP2 cells (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Figure 4</xref>).</p><p hwp:id="p-32">Taken altogether, these data show that p56<sup><italic toggle="yes">lck</italic></sup> can be overexpressed in HeLa CD4 cells, and that this increases the level of CD4 at the surface of cells. HeLa CD4 cells producing p56<sup><italic toggle="yes">lck</italic></sup> can be infected by MCR Env-pseudotyped virions at levels around 10 times higher than untransduced cells. The change in cell-surface CD4 and increase in titres does not occur in NP2 cells that express p56<sup><italic toggle="yes">lck</italic></sup>.</p></sec><sec id="s3g" hwp:id="sec-14"><title hwp:id="title-15">No enhanced infection level is seen on HeLa CD4 cells expressing p56<sup><italic toggle="yes">lck</italic></sup> compared to HeLa CD4 cells for virions with two non CD4-binding envelope proteins</title><p hwp:id="p-33">In order to see if this effect was specific to MCRmediated viral entry, a comparison of titres of VSV-G, amphotropic envelope and MCR-pseudotyped virions was carried out on HeLa CD4 cells expressing p56<sup><italic toggle="yes">lck</italic></sup>, or on the parental p56<sup><italic toggle="yes">lck</italic></sup>-null cell line. The expression of p56<sup><italic toggle="yes">lck</italic></sup> in HeLa CD4 cells did not change titres for VSV-G or amphotropic Env-pseudotyped virions (Supplementary Figure 5). For MCR-pseudotyped virions, expression of p56<sup><italic toggle="yes">lck</italic></sup> again increased titres by over 10-fold. While titres for VSV-Gpseudotyped virus are 10-fold higher still, the rescue of MCR-pseudotyped virions was to the same levels as amphotropic Env without p56<sup><italic toggle="yes">lck</italic></sup>. This shows that p56<sup><italic toggle="yes">lck</italic></sup> expression can rescue titres of virions pseudotyped with MCR Env, but has no effect on virions pseudotyped with VSV-G or amphotropic Env.</p></sec></sec><sec id="s4" hwp:id="sec-15"><title hwp:id="title-16"><sc>Discussion</sc></title><p hwp:id="p-34">Cells can be artificially engineered to express combinations of retroviral receptors, but expression alone may be insufficient to render these cells permissive to infection by the cognate virus. HeLa CD4 cells are fully permissive to infection by HIV-1 cores pseudotyped with VSV-G, but not to those pseudotyped with an envelope protein derived from a primary isolate, MCR. U87 and NP2 cells, however, are fully permissive to viruses pseudotyped with both envelope proteins. All cell types are clearly capable of supporting retroviral infection. Experiments that compare VSV-G, MCR Env and MCN Env are at best relative, as different virus populations must be used. An attempt was made to recapitulate the blockage using overexpression of Tva800 and Tva950 in HeLa CD4 cells. These are the two forms of receptor for Avian sarcoma leucosis virus which facilitate viral entry through two different routes in the cell, and would permit use of the same virus (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">Narayan et al., 2003</xref>, <xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">Gray et al., 2011</xref>). However, no difference in viral infection was seen between the two receptors.</p><p hwp:id="p-35">As this study shows by qPCR that MCR Envpseudotyped virions do not enter cells and reverse transcribe at sufficient levels for a productive infection, it was necessary to consider what factor(s) could be responsible for low viral infectivity, including the entry process. Two receptors, CD4 and CXCR4, are necessary for entry via MCR (<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">McKnight et al., 1998</xref>). Cloning and sequencing of the CD4 receptor from HeLa CD4 cells showed no non-synonymous mutations compared to the expected coding sequence from <italic toggle="yes">NM</italic>_000616. As overall expression levels of CD4 appeared to be as expected (Supplementary Figure 3 and reference (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">Oliveira et al., 2010</xref>)), we investigated whether a defect in receptor usage could be detected. In order to assess this, a fusion marker, S15-mCherry was used. The data show that MCR Env pseudotyped virions are less likely to fuse with HeLa CD4 cells, and that possibly a reduced absolute number of virions (about 25% and 50% compared to NP2 and U87 cells respectively) bind to HeLa CD4 cells. The qPCR and microscopy data strongly suggest that the block to infection of MCR Env-pseudotyped virions occurs at fusion, and therefore entry.</p><p hwp:id="p-36">If successful fusion is not occurring, this could be due to several factors. The virions used to infect HeLa CD4 and NP2 or U87 cells were always the same batch within experiments. There could be a problem with CD4 expression in HeLa CD4 cells, but this is unlikely given it was robustly detected by Western blot of whole cell lysates (Supplementary Figure 3). Interestingly, while these cells are routinely used in CD4-tropic viral titration assays, previous studies showed that for some viruses infectivity on HeLa CD4 cells is correlated with expression level of CD4, including a threshold minimum for NL4-3 Env pseudotyped viruses (<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">Kabat et al., 1994</xref>, <xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-2" hwp:rel-id="ref-26">Kozak et al., 1997</xref>, <xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">Walter et al., 2005</xref>). This study by Kozak et al. reported a similar phenomenon to Lv2 whereby primary patient isolates exhibited different infectivities on U87 and a panel of HeLa CD4 cell clones expressing different levels of CD4 (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-3" hwp:rel-id="ref-26">Kozak et al., 1997</xref>). The HeLa CD4 cells used in this and previous studies may well be expressing CD4 at the cell surface that is below this minimum threshold. CD4 is not found at high concentration at the cell surface of non-thymocytes due to rapid endocytosis, and our data with p56<sup><italic toggle="yes">lck</italic></sup> illustrate the importance of cell-surface expression on the observed phenotype. Another possible explanation is that MCR may be binding, but is not able to initiate fusion before the virus-CD4 complex is endocytosed and inactivated by low pH in endosomes. This is not normally a productive entry pathway for HIV (<xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">Permanyer et al., 2010</xref>).</p><p hwp:id="p-37">MCR was derived from a primary isolate, and therefore may be adapted for physiological conditions rather than the tissue culture conditions described in these experiments. It has previously been shown that infectivity of primary isolates is proportional to the level of CD4 expressed on cells, but that this is not a limiting factor for laboratory-adapted strains, and suggested that this is an adaptation to allow these viruses to avoid infections on nonproductive cell types (<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-2" hwp:rel-id="ref-24">Kabat et al., 1994</xref>, <xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-2" hwp:rel-id="ref-48">Platt et al., 2000</xref>). In vivo, MCR envelope would interact with CD4 on cells of lymphocytic origin, which have regulatory mechanisms to ensure CD4 remains at the cell surface, and not with cells of non-lymphocytic origin. Experiments described here in which titres of MCR pseudotyped virions are increased over 10-fold by expression of p56<sup><italic toggle="yes">lck</italic></sup> support the suggestion that lack of CD4-regulatory mechanisms in HeLa CD4 cells could comprise a component of the block. The addition of p56<sup><italic toggle="yes">lck</italic></sup> restores some part of these mechanisms, and other protein players are highly likely. Neither an increase in the ratio of cell-surface to intracellular CD4, nor a decrease in the rate of endocytosis should affect entry by VSV-G or amphotropic virus (as seen), showing that the effect of p56<sup><italic toggle="yes">lck</italic></sup> is specific to CD4-binding virions.</p><p hwp:id="p-38">The block to infection to MCR-pseudotyped viruses in HeLa CD4 cells is only part of a wider phenomenon, and it must be considered why there is no block in NP2 and U87 cells, which, as astrocytoma cells and non-lymphoid in origin, do not normally express endogenous p56<sup><italic toggle="yes">lck</italic></sup>. However, it has been suggested that p56<sup><italic toggle="yes">lck</italic></sup> is expressed in rat and mouse brains (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">Omri et al., 1996</xref>, Van <xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">Tan et al., 1996</xref>). This serves to highlight the difference between cells of different lineages and origins. If the difference between NP2, U87 and HeLa CD4 were to be probed further, it would be interesting to widen the screen well beyond p56<sup><italic toggle="yes">lck</italic></sup>, and to look at expression profiles across HeLa, NP2, U87 and lymphocytes of other proteins known to interact with CD4 as other factors may be responsible for the regulation of CD4 (or lack thereof) in other cell types. The titration data for MCN Env and NL43 Env pseudotyped virions show that the block to infection is not unique to MCR Env, and further CD4/CXCR4-tropic envelopes could also be investigated.</p><p hwp:id="p-39">It has been suggested that the difference between HeLa CD4 and NP2 cells is due to an intracellular restriction factor present in a specific compartment of HeLa CD4 cells that inhibits viral cores similarly to Trim5<italic toggle="yes">α</italic> or Fv1 (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-5" hwp:rel-id="ref-57">Stremlau et al., 2004</xref>, <xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">Best et al., 1996</xref>, <xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-11" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>), and that rerouting virus around this compartment (e.g. by VSV-G) enables the virus to avoid this block. For a late entry block (e.g. Fv1n) it can be ascertained that fusion and entry are occurring by comparing levels of both early and late reverse transcription products (i.e. for N-(unrestricted) and B-(restricted) tropic MLV (<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">Jolicoeur and Rassart, 1980</xref>)). For an early block, (e.g. Trim5<italic toggle="yes">α</italic>) levels of early products of restricted and unrestricted virus are not comparable as the block is pre-reverse transcription (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-6" hwp:rel-id="ref-57">Stremlau et al., 2004</xref>). However, the saturable nature of Trim5<italic toggle="yes">α</italic> (and Fv1) overwhelmingly indicates that a post-entry, cytosolic restriction factor is involved, rather than a block at the level of fusion and entry, whereas no abrogation was achieved for MCR-pseudotyped virus on HeLa CD4 cells (Supplementary Figure 2, see (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-2" hwp:rel-id="ref-13">Dodding et al., 2005</xref>, <xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">Hatziioannou et al., 2003</xref>) for comparison). The block could be either nonsaturable in nature, or expressed at too high a concentration to saturate. In HeLa CD4 cells infected with MCR-pseudotyped virus, levels of reverse transcription products do not accrue to those comparable to a successful infection and it is less likely that the block is definitively caused by a specific restriction factor, or through passage via a particular cell compartment, as there is no indication that the infection would otherwise be successful.</p><p hwp:id="p-40">These experiments were carried out in order to investigate an aspect of Lv2 as proposed by previous studies. Instead of independently creating an exact replica of previous studies, we sought instead to use different methods to shed light from an alternative angle. Where experiments from prior studies were repeated, the data shown here were similar to those previously. To take <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figure 2</xref> as an example, Schmitz et al. showed ratios of strong-stop products produced from HeLa CD4 cells and compared them to the levels from U87 cells for both MCRand MCN-pseudotyped viruses, showing the data as a fold-restriction ratio (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-12" hwp:rel-id="ref-53">Schmitz et al., 2004</xref>). The fold-difference (i.e. the ratio of transcripts) in U87 cells at all timepoints for MCR Env-pseudotyped virions is between 7 to 25fold higher than in HeLa CD4 cells. Those data are in agreement with these presented here, as <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figure 2</xref> shows a strong-stop products ratio of approximately 5-fold of unrestricted cells compared to HeLa CD4. Again, data from a similar (though non-quantitative) experiment are shown in McKnight et al. (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-3" hwp:rel-id="ref-33">McKnight et al., 2001</xref>), where the two initial primary isolates, prCBL23 and CBL23, are compared. Although the levels of reverse transcripts for the two isolates are the same when considered on each cell type individually, between cell types the levels are very different (with much higher levels produced from U87 cells than the restrictive HeLa CD4 or HOS cells). Those data are again commensurate with <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Figure 2</xref> of this study.</p><p hwp:id="p-41">Data from this study can also be compared to previous studies with different methodologies. In Reuter et al. an experimental technique that discriminates between fusion and endocytosis was used to investigate the block to MCR pseudotyped virions, known as the BlaM-vpr assay, from which the results can be compared to those in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Figure 3</xref> (<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">Cavrois et al., 2002</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-6" hwp:rel-id="ref-49">Reuter et al., 2005</xref>). Briefly, Reuter et al. reported that entry via restricted Env proteins, which included Env35 (or MCR), was between 2.5 to 3-fold less efficient compared to entry via unrestricted Env proteins. This is in concordance with the results in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-8" hwp:rel-id="F3">Figure 3</xref>, where a level of 4 to 5-fold less fusion was observed in restricted HeLa CD4 cells compared to unrestricted NP2 or U87 cells. Again, the data are in agreement, though the subsequent conclusions drawn may differ.</p><p hwp:id="p-42">In experiments detailed in this study we have studied a phenomenon carefully by standard and novel techniques, and report that while there is a block to infection of MCRpseudotyped virions in HeLa CD4 cells, this is at entry and could be due to phenomena other than a restriction factor (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">Goff, 2004</xref>, <xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">Sorin and Kalpana, 2006</xref>). Experiments described here confirm the original phenotype of MCR Env and the results are concordant with those from previous papers. Some cells can be infected by MCR Env pseudotyped virus, but other cells expressing the same combination of receptor and co-receptor are not, but this artificial combination of cells and receptors could highlight an artefact of cell biology, and CD4 interaction with the Env of primary isolates (<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-3" hwp:rel-id="ref-24">Kabat et al., 1994</xref>). Virion entry levels are not commensurate with a successful infection, and fusion of MCR with HeLa CD4 cells is reduced compared to NP2 or U87 cells. The block to infection, therefore, occurs at viral entry, and can be modulated by cellular factors that interact with CD4. A plausible explanation of the primary cause of this phenomenon is differences in cell biology between NP2, U87 and HeLa CD4 cells with inhibition of the viral lifecycle at the stages of fusion and entry.</p></sec></body><back><sec id="s5" hwp:id="sec-16"><title hwp:id="title-17"><sc>Additional Information</sc></title><ack hwp:id="ack-1"><title hwp:id="title-18">Acknowledgements</title><p hwp:id="p-43">ERG thanks Melvyn Yap for technical assistance and discussions, Laura Hilditch for randomising the microscopy images and for comments on the manuscript; Daniel Ashley Richards, Petra Mlcochova and Doug King for access to facilities. This work was supported by a Medical Research Council studentship to ERG and conducted in the laboratory of Dr Jonathan Stoye, with additional support from EPSRC EP/K031953/1 i-sense: Early Warning Sensing Systems for Infectious Disease.</p></ack></sec><sec id="s6" hwp:id="sec-17"><title hwp:id="title-19">Conflict of interest</title><p hwp:id="p-44">The author declares that no competing financial interests exist.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-20"><sc>References</sc></title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Aiken Christopher"><given-names>Christopher</given-names> <surname>Aiken</surname></string-name>. <article-title hwp:id="article-title-2">Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for nef and the sensitivity to Cyclosporin A</article-title>. <source hwp:id="source-1">Journal of Virology</source>, <volume>71</volume>(<issue>8</issue>):<fpage>5871</fpage>–<lpage>5877</lpage>, August <year>1997</year>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Anderson J L"><given-names>J L</given-names> <surname>Anderson</surname></string-name>, <string-name name-style="western" hwp:sortable="Campbell E M"><given-names>E M</given-names> <surname>Campbell</surname></string-name>, <string-name name-style="western" hwp:sortable="Wu X"><given-names>X</given-names> <surname>Wu</surname></string-name> <string-name name-style="western" hwp:sortable="Vandegraaff N"><given-names>N</given-names> <surname>Vandegraaff</surname></string-name> <string-name name-style="western" hwp:sortable="Engelman A"><given-names>A</given-names> <surname>Engelman</surname></string-name> and <string-name name-style="western" hwp:sortable="Hope T J"><given-names>T J</given-names> <surname>Hope</surname></string-name>. <article-title hwp:id="article-title-3">Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins</article-title>. <source hwp:id="source-2">Journal of Virology</source>, <volume>80</volume>(<issue>19</issue>): <fpage>9754</fpage>–<lpage>9760</lpage>, September <year>2006</year>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Bainbridge J W"><given-names>J W</given-names> <surname>Bainbridge</surname></string-name>, <string-name name-style="western" hwp:sortable="Stephens C"><given-names>C</given-names> <surname>Stephens</surname></string-name> <string-name name-style="western" hwp:sortable="Parsley K"><given-names>K</given-names> <surname>Parsley</surname></string-name> <string-name name-style="western" hwp:sortable="Demaison C"><given-names>C</given-names> <surname>Demaison</surname></string-name> <string-name name-style="western" hwp:sortable="Halfyard A"><given-names>A</given-names> <surname>Halfyard</surname></string-name> <string-name name-style="western" hwp:sortable="Thrasher A J"><given-names>A J</given-names> <surname>Thrasher</surname></string-name>, and <string-name name-style="western" hwp:sortable="Ali R R"><given-names>R R</given-names> <surname>Ali</surname></string-name>. <article-title hwp:id="article-title-4">In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium</article-title>. <source hwp:id="source-3">Gene Therapy</source>, <volume>8</volume>(<issue>21</issue>):<fpage>1665</fpage>–<lpage>1668</lpage>, November <year>2001</year>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Besnier Caroline"><given-names>Caroline</given-names> <surname>Besnier</surname></string-name> <string-name name-style="western" hwp:sortable="Takeuchi Yasuhiro"><given-names>Yasuhiro</given-names> <surname>Takeuchi</surname></string-name> and <string-name name-style="western" hwp:sortable="Towers Greg"><given-names>Greg</given-names> <surname>Towers</surname></string-name>. <article-title hwp:id="article-title-5">Restriction of lentivirus in monkeys</article-title>. <source hwp:id="source-4">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>99</volume>(<issue>18</issue>):<fpage>11920</fpage>– <lpage>11925</lpage>, September <year>2002</year>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Best S"><given-names>S</given-names> <surname>Best</surname></string-name> <string-name name-style="western" hwp:sortable="Le Tissier P"><given-names>P</given-names> <surname>Le Tissier</surname></string-name> <string-name name-style="western" hwp:sortable="Towers G"><given-names>G</given-names> <surname>Towers</surname></string-name> and <string-name name-style="western" hwp:sortable="Stoye J P"><given-names>J P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-6">Positional cloning of the mouse retrovirus restriction gene Fv1</article-title>. <source hwp:id="source-5">Nature</source>, <volume>382</volume>(<issue>6594</issue>):<fpage>826</fpage>– <lpage>829</lpage>, August <year>1996</year>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Björndal Åsa"><given-names>Åsa</given-names> <surname>Björndal</surname></string-name>, <string-name name-style="western" hwp:sortable="Deng Hongkui"><given-names>Hongkui</given-names> <surname>Deng</surname></string-name> <string-name name-style="western" hwp:sortable="Jansson Marianne"><given-names>Marianne</given-names> <surname>Jansson</surname></string-name> <string-name name-style="western" hwp:sortable="Fiore José R"><given-names>José R</given-names> <surname>Fiore</surname></string-name> <string-name name-style="western" hwp:sortable="Colognesi Claudia"><given-names>Claudia</given-names> <surname>Colognesi</surname></string-name> <string-name name-style="western" hwp:sortable="Karlsson Anders"><given-names>Anders</given-names> <surname>Karlsson</surname></string-name> <string-name name-style="western" hwp:sortable="Scarlatti Jan Albert Gabriella"><given-names>Jan Albert Gabriella</given-names> <surname>Scarlatti</surname></string-name> <string-name name-style="western" hwp:sortable="Littman Dan R"><given-names>Dan R</given-names> <surname>Littman</surname></string-name>, and <string-name name-style="western" hwp:sortable="Fenyö Eva Maria"><given-names>Eva Maria</given-names> <surname>Fenyö</surname></string-name>. <article-title hwp:id="article-title-7">Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype</article-title>. <source hwp:id="source-6">Journal of Virology</source>, <volume>71</volume>(<issue>10</issue>):<fpage>7478</fpage>–<lpage>7487</lpage>, September <year>1997</year>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2 xref-ref-7-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Bock M"><given-names>M</given-names> <surname>Bock</surname></string-name> <string-name name-style="western" hwp:sortable="Bishop K N"><given-names>K N</given-names> <surname>Bishop</surname></string-name>, <string-name name-style="western" hwp:sortable="Towers G"><given-names>G</given-names> <surname>Towers</surname></string-name> and <string-name name-style="western" hwp:sortable="Stoye J P"><given-names>J P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-8">Use of a transient assay for studying the genetic determinants of Fv1 restriction</article-title>. <source hwp:id="source-7">Journal of Virology</source>, <volume>74</volume>(<issue>16</issue>):<fpage>7422</fpage>–<lpage>7430</lpage>, August <year>2000</year>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Brindley Melinda A"><given-names>Melinda A</given-names> <surname>Brindley</surname></string-name> and <string-name name-style="western" hwp:sortable="Maury Wendy"><given-names>Wendy</given-names> <surname>Maury</surname></string-name>. <article-title hwp:id="article-title-9">Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus</article-title>. <source hwp:id="source-8">J Virol</source>, <volume>79</volume>(<issue>23</issue>):<fpage>14482</fpage>–<lpage>14488</lpage>, December <year>2005</year>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Bruce J W"><given-names>J W</given-names> <surname>Bruce</surname></string-name>, <string-name name-style="western" hwp:sortable="Bradley K A"><given-names>K A</given-names> <surname>Bradley</surname></string-name>, <string-name name-style="western" hwp:sortable="Ahlquist P"><given-names>P</given-names> <surname>Ahlquist</surname></string-name> and <string-name name-style="western" hwp:sortable="Young J A T"><given-names>J A T</given-names> <surname>Young</surname></string-name>. <article-title hwp:id="article-title-10">Isolation of Cell Lines That Show Novel Murine Leukemia Virus-Specific Blocks to Early Steps of Retroviral Replication</article-title>. <source hwp:id="source-9">Journal of Virology</source>, <volume>79</volume>(<issue>20</issue>):<fpage>12969</fpage>–<lpage>12978</lpage>, September <year>2005</year>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2 xref-ref-10-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Campbell Edward M"><given-names>Edward M</given-names> <surname>Campbell</surname></string-name>, <string-name name-style="western" hwp:sortable="Perez Omar"><given-names>Omar</given-names> <surname>Perez</surname></string-name> <string-name name-style="western" hwp:sortable="Melar Marta"><given-names>Marta</given-names> <surname>Melar</surname></string-name> and <string-name name-style="western" hwp:sortable="Hope Thomas J"><given-names>Thomas J</given-names> <surname>Hope</surname></string-name>. <article-title hwp:id="article-title-11">Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell</article-title>. <source hwp:id="source-10">Virology</source>, <volume>360</volume>(<issue>2</issue>):<fpage>286</fpage>–<lpage>293</lpage>, April <year>2007</year>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Cavrois Marielle"><given-names>Marielle</given-names> <surname>Cavrois</surname></string-name> <string-name name-style="western" hwp:sortable="Noronha Carlos De"><given-names>Carlos De</given-names> <surname>Noronha</surname></string-name> and <string-name name-style="western" hwp:sortable="Greene Warner C"><given-names>Warner C</given-names> <surname>Greene</surname></string-name>. <article-title hwp:id="article-title-12">A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes</article-title>. <source hwp:id="source-11">Nature Biotechnology</source>, <volume>20</volume>(<issue>11</issue>):<fpage>1151</fpage>–<lpage>1154</lpage>, November <year>2002</year>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Cecilia D"><given-names>D</given-names> <surname>Cecilia</surname></string-name> <string-name name-style="western" hwp:sortable="Kewalramanl Vineet N"><given-names>Vineet N</given-names> <surname>Kewalramanl</surname></string-name>, <string-name name-style="western" hwp:sortable="O’Leary Jeanne"><given-names>Jeanne</given-names> <surname>O’Leary</surname></string-name>, <string-name name-style="western" hwp:sortable="Volsky Barbara"><given-names>Barbara</given-names> <surname>Volsky</surname></string-name> <string-name name-style="western" hwp:sortable="Nyambi Phillipe"><given-names>Phillipe</given-names> <surname>Nyambi</surname></string-name> <string-name name-style="western" hwp:sortable="Burda Sherri"><given-names>Sherri</given-names> <surname>Burda</surname></string-name> <string-name name-style="western" hwp:sortable="Xu Serena"><given-names>Serena</given-names> <surname>Xu</surname></string-name> <string-name name-style="western" hwp:sortable="Littman Dan R"><given-names>Dan R</given-names> <surname>Littman</surname></string-name>, and <string-name name-style="western" hwp:sortable="Zolla-Pazner Susan"><given-names>Susan</given-names> <surname>Zolla-Pazner</surname></string-name>. <article-title hwp:id="article-title-13">Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage</article-title>. <source hwp:id="source-12">Journal of Virology</source>, <volume>72</volume>(<issue>9</issue>):<fpage>6988</fpage>–<lpage>6996</lpage>, September <year>1998</year>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1 xref-ref-13-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Dodding Mark P"><given-names>Mark P</given-names> <surname>Dodding</surname></string-name>, <string-name name-style="western" hwp:sortable="Bock Michael"><given-names>Michael</given-names> <surname>Bock</surname></string-name> <string-name name-style="western" hwp:sortable="Yap Melvyn W"><given-names>Melvyn W</given-names> <surname>Yap</surname></string-name>, and <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-14">Capsid processing requirements for abrogation of Fv1 and Ref1 restriction</article-title>. <source hwp:id="source-13">J Virol</source>, <volume>79</volume>(<issue>16</issue>):<fpage>10571</fpage>–<lpage>10577</lpage>, August <year>2005</year>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Fletcher A J"><given-names>A J</given-names> <surname>Fletcher</surname></string-name>, <string-name name-style="western" hwp:sortable="Hue S"><given-names>S</given-names> <surname>Hue</surname></string-name> <string-name name-style="western" hwp:sortable="Schaller T"><given-names>T</given-names> <surname>Schaller</surname></string-name> <string-name name-style="western" hwp:sortable="Pillay D"><given-names>D</given-names> <surname>Pillay</surname></string-name> and <string-name name-style="western" hwp:sortable="Towers G J"><given-names>G J</given-names> <surname>Towers</surname></string-name>. <article-title hwp:id="article-title-15">Hare TRIM5 Restricts Divergent Retroviruses and Exhibits Significant Sequence Variation from Closely Related Lagomorpha TRIM5 Genes</article-title>. <source hwp:id="source-14">Journal of Virology</source>, <volume>84</volume> (<issue>23</issue>):<fpage>12463</fpage>–<lpage>12468</lpage>, November <year>2010</year>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Foti M"><given-names>M</given-names> <surname>Foti</surname></string-name> <string-name name-style="western" hwp:sortable="Phelouzat M-A"><given-names>M-A</given-names> <surname>Phelouzat</surname></string-name> <string-name name-style="western" hwp:sortable="Holm A"><given-names>A</given-names> <surname>Holm</surname></string-name> <string-name name-style="western" hwp:sortable="Rasmusson B J"><given-names>B J</given-names> <surname>Rasmusson</surname></string-name>, and <string-name name-style="western" hwp:sortable="Carpentier J-L"><given-names>J-L</given-names> <surname>Carpentier</surname></string-name>. <article-title hwp:id="article-title-16">p56lck anchors CD4 to distinct microdomains on microvilli</article-title>. <source hwp:id="source-15">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>99</volume>(<issue>4</issue>):<fpage>2008</fpage>–<lpage>2013</lpage>, February <year>2002</year>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Friend C"><given-names>C</given-names> <surname>Friend</surname></string-name>. <article-title hwp:id="article-title-17">Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia</article-title>. <source hwp:id="source-16">The Journal of experimental medicine</source>, <volume>105</volume>(<issue>4</issue>):<fpage>307</fpage>–<lpage>318</lpage>, April <year>1957a</year>.</citation></ref><ref id="c17" hwp:id="ref-17"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Friend C"><given-names>C</given-names> <surname>Friend</surname></string-name>. <article-title hwp:id="article-title-18">Leukemia of adult mice caused by a transmissible agent</article-title>. <source hwp:id="source-17">Ann N Y Acad Sci</source>, <volume>68</volume>(<issue>2</issue>): <fpage>522</fpage>–<lpage>532</lpage>, October <year>1957b</year>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Gao Guangxia"><given-names>Guangxia</given-names> <surname>Gao</surname></string-name> and <string-name name-style="western" hwp:sortable="Goff Stephen P"><given-names>Stephen P</given-names> <surname>Goff</surname></string-name>. <article-title hwp:id="article-title-19">Somatic cell mutants resistant to retrovirus replication: Intracellular blocks during the early stages of infection</article-title>. <source hwp:id="source-18">Molecular Biology of the Cell</source>, <volume>10</volume>(<issue>6</issue>): <fpage>1705</fpage>–<lpage>1717</lpage>, June <year>1999</year>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Goff Stephen P"><given-names>Stephen P</given-names> <surname>Goff</surname></string-name>. <article-title hwp:id="article-title-20">Retrovirus Restriction Factors</article-title>. <source hwp:id="source-19">Molecular Cell</source>, <volume>16</volume>(<issue>6</issue>):<fpage>849</fpage>–<lpage>859</lpage>, December <year>2004</year>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Gray Eleanor R"><given-names>Eleanor R</given-names> <surname>Gray</surname></string-name>, <string-name name-style="western" hwp:sortable="Illingworth Christopher JR"><given-names>Christopher JR</given-names> <surname>Illingworth</surname></string-name> <string-name name-style="western" hwp:sortable="Coffin John M"><given-names>John M</given-names> <surname>Coffin</surname></string-name>, and <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-21">Binding of more than one Tva800 molecule is required for ASLV-A entry</article-title>. <source hwp:id="source-20">Retrovirology</source>, <volume>8</volume>(<issue>1</issue>): <fpage>96</fpage>, November <year>2011</year>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Harrison I P"><given-names>I P</given-names> <surname>Harrison</surname></string-name> and <string-name name-style="western" hwp:sortable="McKnight A"><given-names>A</given-names> <surname>McKnight</surname></string-name>. <article-title hwp:id="article-title-22">Cellular entry via an actin and clathrin-dependent route is required for Lv2 restriction of HIV-2</article-title>. <source hwp:id="source-21">Virology</source>, <volume>415</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>55</lpage>, June <year>2011</year>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Hatziioannou Theodora"><given-names>Theodora</given-names> <surname>Hatziioannou</surname></string-name>, <string-name name-style="western" hwp:sortable="Cowan Simone"><given-names>Simone</given-names> <surname>Cowan</surname></string-name>, <string-name name-style="western" hwp:sortable="Goff Stephen P"><given-names>Stephen P</given-names> <surname>Goff</surname></string-name>, <string-name name-style="western" hwp:sortable="Bieniasz Paul D"><given-names>Paul D</given-names> <surname>Bieniasz</surname></string-name>, and <string-name name-style="western" hwp:sortable="Towers Greg J"><given-names>Greg J</given-names> <surname>Towers</surname></string-name>. <article-title hwp:id="article-title-23">Restriction of multiple divergent retroviruses by Lv1 and Ref1</article-title>. <source hwp:id="source-22">EMBO Journal</source>, <volume>22</volume>(<issue>3</issue>):<fpage>385</fpage>–<lpage>394</lpage>, February <year>2003</year>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Jolicoeur P"><given-names>P</given-names> <surname>Jolicoeur</surname></string-name> and <string-name name-style="western" hwp:sortable="Rassart E"><given-names>E</given-names> <surname>Rassart</surname></string-name>. <article-title hwp:id="article-title-24">Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus</article-title>. <source hwp:id="source-23">Journal of Virology</source>, <volume>33</volume> (<issue>1</issue>):<fpage>183</fpage>–<lpage>195</lpage>, January <year>1980</year>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1 xref-ref-24-2 xref-ref-24-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Kabat D"><given-names>D</given-names> <surname>Kabat</surname></string-name>, <string-name name-style="western" hwp:sortable="Kozak S L"><given-names>S L</given-names> <surname>Kozak</surname></string-name>, <string-name name-style="western" hwp:sortable="Wehrly K"><given-names>K</given-names> <surname>Wehrly</surname></string-name>, and <string-name name-style="western" hwp:sortable="Chesebro B"><given-names>B</given-names> <surname>Chesebro</surname></string-name>. <article-title hwp:id="article-title-25">Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1</article-title>. <source hwp:id="source-24">J Virol</source>, <volume>68</volume>(<issue>4</issue>):<fpage>2570</fpage>–<lpage>2577</lpage>, April <year>1994</year>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Keckesova Zuzana"><given-names>Zuzana</given-names> <surname>Keckesova</surname></string-name>, <string-name name-style="western" hwp:sortable="Ylinen Laura M J"><given-names>Laura M J</given-names> <surname>Ylinen</surname></string-name>, and <string-name name-style="western" hwp:sortable="Towers Greg J"><given-names>Greg J</given-names> <surname>Towers</surname></string-name>. <article-title hwp:id="article-title-26">The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities</article-title>. <source hwp:id="source-25">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>101</volume>(<issue>29</issue>):<fpage>10780</fpage>– <lpage>10785</lpage>, July <year>2004</year>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1 xref-ref-26-2 xref-ref-26-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Kozak S L"><given-names>S L</given-names> <surname>Kozak</surname></string-name>, <string-name name-style="western" hwp:sortable="Platt E J"><given-names>E J</given-names> <surname>Platt</surname></string-name>, <string-name name-style="western" hwp:sortable="Madani N"><given-names>N</given-names> <surname>Madani</surname></string-name>, <string-name name-style="western" hwp:sortable="Ferro F E"><given-names>F E</given-names> <surname>Ferro</surname></string-name>, <string-name name-style="western" hwp:sortable="Peden K"><given-names>K</given-names> <surname>Peden</surname></string-name> and <string-name name-style="western" hwp:sortable="Kabat D"><given-names>D</given-names> <surname>Kabat</surname></string-name>. <article-title hwp:id="article-title-27">CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1</article-title>. <source hwp:id="source-26">J Virol</source>, <volume>71</volume>(<issue>2</issue>):<fpage>873</fpage>–<lpage>882</lpage>, February <year>1997</year>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Lennon Greg"><given-names>Greg</given-names> <surname>Lennon</surname></string-name>, <string-name name-style="western" hwp:sortable="Auffray Charles"><given-names>Charles</given-names> <surname>Auffray</surname></string-name>, <string-name name-style="western" hwp:sortable="Polymeropoulos Mihael"><given-names>Mihael</given-names> <surname>Polymeropoulos</surname></string-name>, and <string-name name-style="western" hwp:sortable="Bento Soares Marcelo"><given-names>Marcelo</given-names> <surname>Bento Soares</surname></string-name>. <article-title hwp:id="article-title-28">The I.M.A.G.E consortium: An integrated molecular analysis of genomes and their expression</article-title>. <source hwp:id="source-27">Genomics</source>, <volume>33</volume>(<issue>1</issue>):<fpage>151</fpage>–<lpage>152</lpage>, April <year>1996</year>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Lilly F"><given-names>F</given-names> <surname>Lilly</surname></string-name>. <article-title hwp:id="article-title-29">Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice</article-title>. <source hwp:id="source-28">J Natl Cancer Inst</source>, <volume>45</volume>(<issue>1</issue>):<fpage>163</fpage>–<lpage>169</lpage>, July <year>1970</year>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Maddon P J"><given-names>P J</given-names> <surname>Maddon</surname></string-name>, <string-name name-style="western" hwp:sortable="Dalgleish A G"><given-names>A G</given-names> <surname>Dalgleish</surname></string-name>, <string-name name-style="western" hwp:sortable="McDougal J S"><given-names>J S</given-names> <surname>McDougal</surname></string-name>, <string-name name-style="western" hwp:sortable="Clapham P R"><given-names>P R</given-names> <surname>Clapham</surname></string-name>, <string-name name-style="western" hwp:sortable="Weiss R A"><given-names>R A</given-names> <surname>Weiss</surname></string-name>, and <string-name name-style="western" hwp:sortable="Axel R"><given-names>R</given-names> <surname>Axel</surname></string-name>. <article-title hwp:id="article-title-30">The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain</article-title>. <source hwp:id="source-29">Cell</source>, <volume>47</volume>(<issue>3</issue>):<fpage>333</fpage>–<lpage>348</lpage>, November <year>1986</year>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1 xref-ref-30-2 xref-ref-30-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Marchant David"><given-names>David</given-names> <surname>Marchant</surname></string-name> <string-name name-style="western" hwp:sortable="Neil Stuart J D"><given-names>Stuart J D</given-names> <surname>Neil</surname></string-name>, <string-name name-style="western" hwp:sortable="Aubin Keith"><given-names>Keith</given-names> <surname>Aubin</surname></string-name> <string-name name-style="western" hwp:sortable="Schmitz Christian"><given-names>Christian</given-names> <surname>Schmitz</surname></string-name> and <string-name name-style="western" hwp:sortable="McKnight Aine"><given-names>Aine</given-names> <surname>McKnight</surname></string-name>. <article-title hwp:id="article-title-31">An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type 1 (HIV-1) and HIV-2 to Lv2 restriction</article-title>. <source hwp:id="source-30">J Virol</source>, <volume>79</volume>(<issue>15</issue>):<fpage>9410</fpage>–<lpage>9418</lpage>, August <year>2005</year>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1 xref-ref-31-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="McDonald David"><given-names>David</given-names> <surname>McDonald</surname></string-name>, <string-name name-style="western" hwp:sortable="Vodicka Marie A"><given-names>Marie A</given-names> <surname>Vodicka</surname></string-name>, <string-name name-style="western" hwp:sortable="Lucero Ginger"><given-names>Ginger</given-names> <surname>Lucero</surname></string-name> <string-name name-style="western" hwp:sortable="Svitkina Tatyana M"><given-names>Tatyana M</given-names> <surname>Svitkina</surname></string-name>, <string-name name-style="western" hwp:sortable="Borisy Gary G"><given-names>Gary G</given-names> <surname>Borisy</surname></string-name>, <string-name name-style="western" hwp:sortable="Emerman Michael"><given-names>Michael</given-names> <surname>Emerman</surname></string-name>, and <string-name name-style="western" hwp:sortable="Hope Thomas J"><given-names>Thomas J</given-names> <surname>Hope</surname></string-name>. <article-title hwp:id="article-title-32">Visualization of the intracellular behavior of HIV in living cells</article-title>. <source hwp:id="source-31">The Journal of Cell Biology</source>, <volume>159</volume> (<issue>3</issue>):<fpage>441</fpage>–<lpage>452</lpage>, November <year>2002</year>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="McKnight A"><given-names>A</given-names> <surname>McKnight</surname></string-name> <string-name name-style="western" hwp:sortable="Dittmar M T"><given-names>M T</given-names> <surname>Dittmar</surname></string-name>, <string-name name-style="western" hwp:sortable="Moniz-Periera J"><given-names>J</given-names> <surname>Moniz-Periera</surname></string-name>, <string-name name-style="western" hwp:sortable="Ariyoshi K"><given-names>K</given-names> <surname>Ariyoshi</surname></string-name>, <string-name name-style="western" hwp:sortable="Reeves J D"><given-names>J D</given-names> <surname>Reeves</surname></string-name>, <string-name name-style="western" hwp:sortable="Hibbitts S"><given-names>S</given-names> <surname>Hibbitts</surname></string-name>, <string-name name-style="western" hwp:sortable="Whitby D"><given-names>D</given-names> <surname>Whitby</surname></string-name>, <string-name name-style="western" hwp:sortable="Aarons E"><given-names>E</given-names> <surname>Aarons</surname></string-name>, <string-name name-style="western" hwp:sortable="Proudfoot AEI"><given-names>AEI</given-names> <surname>Proudfoot</surname></string-name>, <string-name name-style="western" hwp:sortable="Whittle H"><given-names>H</given-names> <surname>Whittle</surname></string-name>, and <string-name name-style="western" hwp:sortable="Clapham P R"><given-names>P R</given-names> <surname>Clapham</surname></string-name>. <article-title hwp:id="article-title-33">A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4</article-title>. <source hwp:id="source-32">J Virol</source>, <volume>72</volume>(<issue>5</issue>):<fpage>4065</fpage>–<lpage>4071</lpage>, May <year>1998</year>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1 xref-ref-33-2 xref-ref-33-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="McKnight A"><given-names>A</given-names> <surname>McKnight</surname></string-name> <string-name name-style="western" hwp:sortable="Griffiths D J"><given-names>D J</given-names> <surname>Griffiths</surname></string-name>, <string-name name-style="western" hwp:sortable="Dittmar M"><given-names>M</given-names> <surname>Dittmar</surname></string-name> <string-name name-style="western" hwp:sortable="Clapham P"><given-names>P</given-names> <surname>Clapham</surname></string-name>, and <string-name name-style="western" hwp:sortable="Thomas E"><given-names>E</given-names> <surname>Thomas</surname></string-name>. <article-title hwp:id="article-title-34">Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2</article-title>. <source hwp:id="source-33">J Virol</source>, <volume>75</volume>(<issue>15</issue>):<fpage>6914</fpage>–<lpage>6922</lpage>, August <year>2001</year>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Mortuza Gulnahar B"><given-names>Gulnahar B</given-names> <surname>Mortuza</surname></string-name>, <string-name name-style="western" hwp:sortable="Dodding Mark P"><given-names>Mark P</given-names> <surname>Dodding</surname></string-name>, <string-name name-style="western" hwp:sortable="Goldstone David C"><given-names>David C</given-names> <surname>Goldstone</surname></string-name>, <string-name name-style="western" hwp:sortable="Haire Lesley F"><given-names>Lesley F</given-names> <surname>Haire</surname></string-name>, <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>, and <string-name name-style="western" hwp:sortable="Taylor Ian A"><given-names>Ian A</given-names> <surname>Taylor</surname></string-name>. <article-title hwp:id="article-title-35">Structure of B-MLV Capsid Amino-terminal Domain Reveals Key Features of Viral Tropism Gag Assembly and Core Formation</article-title>. <source hwp:id="source-34">Journal of Molecular Biology</source>, <volume>376</volume>(<issue>5</issue>):<fpage>1493</fpage>–<lpage>1508</lpage>, March <year>2008</year>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Naldini L"><given-names>L</given-names> <surname>Naldini</surname></string-name>, <string-name name-style="western" hwp:sortable="Blömer U"><given-names>U</given-names> <surname>Blömer</surname></string-name>, <string-name name-style="western" hwp:sortable="Gage F H"><given-names>F H</given-names> <surname>Gage</surname></string-name>, <string-name name-style="western" hwp:sortable="Trono D"><given-names>D</given-names> <surname>Trono</surname></string-name>, and <string-name name-style="western" hwp:sortable="Verma I M"><given-names>I M</given-names> <surname>Verma</surname></string-name>. <article-title hwp:id="article-title-36">Efficient transfer integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector</article-title>. <source hwp:id="source-35">Proceedings of the National Academy of Sciences</source>, <volume>93</volume>(<issue>21</issue>):<fpage>11382</fpage>–<lpage>11388</lpage>, October <year>1996</year>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Narayan S"><given-names>S</given-names> <surname>Narayan</surname></string-name>, <string-name name-style="western" hwp:sortable="Barnard R J O"><given-names>R J O</given-names> <surname>Barnard</surname></string-name>, and <string-name name-style="western" hwp:sortable="Young J A T"><given-names>J A T</given-names> <surname>Young</surname></string-name>. <article-title hwp:id="article-title-37">Two Retroviral Entry Pathways Distinguished by Lipid Raft Association of the Viral Receptor and Differences in Viral Infectivity</article-title>. <source hwp:id="source-36">Journal of Virology</source>, <volume>77</volume>(<issue>3</issue>):<fpage>1977</fpage>–<lpage>1983</lpage>, February <year>2003</year>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Newman Ruchi M"><given-names>Ruchi M</given-names> <surname>Newman</surname></string-name>, <string-name name-style="western" hwp:sortable="Hall Laura"><given-names>Laura</given-names> <surname>Hall</surname></string-name>, <string-name name-style="western" hwp:sortable="Kirmaier Andrea"><given-names>Andrea</given-names> <surname>Kirmaier</surname></string-name>, <string-name name-style="western" hwp:sortable="Pozzi Lu-Ann"><given-names>Lu-Ann</given-names> <surname>Pozzi</surname></string-name>, <string-name name-style="western" hwp:sortable="Pery Erez"><given-names>Erez</given-names> <surname>Pery</surname></string-name>, <string-name name-style="western" hwp:sortable="Farzan Michael"><given-names>Michael</given-names> <surname>Farzan</surname></string-name>, <string-name name-style="western" hwp:sortable="O’Neil Shawn P"><given-names>Shawn P</given-names> <surname>O’Neil</surname></string-name>, and <string-name name-style="western" hwp:sortable="Johnson Welkin"><given-names>Welkin</given-names> <surname>Johnson</surname></string-name>. <article-title hwp:id="article-title-38">Evolution of a TRIM5-CypA splice isoform in old world monkeys</article-title>. <source hwp:id="source-37">PLoS pathogens</source>, <volume>4</volume>(<issue>2</issue>): <fpage>e1000003</fpage>, February <year>2008</year>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Nisole Sébastien"><given-names>Sébastien</given-names> <surname>Nisole</surname></string-name>, <string-name name-style="western" hwp:sortable="Lynch Clare"><given-names>Clare</given-names> <surname>Lynch</surname></string-name>, <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>, and <string-name name-style="western" hwp:sortable="Yap Melvyn W"><given-names>Melvyn W</given-names> <surname>Yap</surname></string-name>. <article-title hwp:id="article-title-39">A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1</article-title>. <source hwp:id="source-38">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>101</volume>(<issue>36</issue>):<fpage>13324</fpage>–<lpage>13328</lpage>, September <year>2004</year>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Ohkura Sadayuki"><given-names>Sadayuki</given-names> <surname>Ohkura</surname></string-name>, <string-name name-style="western" hwp:sortable="Goldstone David C"><given-names>David C</given-names> <surname>Goldstone</surname></string-name>, <string-name name-style="western" hwp:sortable="Yap Melvyn W"><given-names>Melvyn W</given-names> <surname>Yap</surname></string-name>, <string-name name-style="western" hwp:sortable="Holden-Dye Kate"><given-names>Kate</given-names> <surname>Holden-Dye</surname></string-name>, <string-name name-style="western" hwp:sortable="Taylor Ian A"><given-names>Ian A</given-names> <surname>Taylor</surname></string-name>, and <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-40">Novel Escape Mutants Suggest an Extensive TRIM5<italic toggle="yes">a</italic> Binding Site Spanning the Entire Outer Surface of the Murine Leukemia Virus Capsid Protein</article-title>. <source hwp:id="source-39">PLoS Pathogens</source>, <volume>7</volume>(<issue>3</issue>):<fpage>e1002011</fpage>–<lpage>13</lpage>, March <year>2011</year>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Oliveira N M"><given-names>N M</given-names> <surname>Oliveira</surname></string-name>, <string-name name-style="western" hwp:sortable="Trikha R"><given-names>R</given-names> <surname>Trikha</surname></string-name> and <string-name name-style="western" hwp:sortable="McKnight A"><given-names>A</given-names> <surname>McKnight</surname></string-name>. <article-title hwp:id="article-title-41">A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5alpha independent</article-title>. <source hwp:id="source-40">Retrovirology</source>, <volume>7</volume>(<issue>1</issue>):<fpage>81</fpage>, <year>2010</year>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Omri B"><given-names>B</given-names> <surname>Omri</surname></string-name>, <string-name name-style="western" hwp:sortable="Crisanti P"><given-names>P</given-names> <surname>Crisanti</surname></string-name>, <string-name name-style="western" hwp:sortable="Marty M C"><given-names>M C</given-names> <surname>Marty</surname></string-name>, <string-name name-style="western" hwp:sortable="Alliot F"><given-names>F</given-names> <surname>Alliot</surname></string-name>, <string-name name-style="western" hwp:sortable="Fagard R"><given-names>R</given-names> <surname>Fagard</surname></string-name>, <string-name name-style="western" hwp:sortable="Molina T"><given-names>T</given-names> <surname>Molina</surname></string-name>, and <string-name name-style="western" hwp:sortable="Pessac B"><given-names>B</given-names> <surname>Pessac</surname></string-name>. <article-title hwp:id="article-title-42">The Lck ty-rosine kinase is expressed in brain neurons</article-title>. <source hwp:id="source-41">Journal of neurochemistry</source>, <volume>67</volume>(<issue>4</issue>):<fpage>1360</fpage>–<lpage>1364</lpage>, October <year>1996</year>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1 xref-ref-42-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Pelchen-Matthews A"><given-names>A</given-names> <surname>Pelchen-Matthews</surname></string-name>, <string-name name-style="western" hwp:sortable="Armes J E"><given-names>J E</given-names> <surname>Armes</surname></string-name>, <string-name name-style="western" hwp:sortable="Griffiths G"><given-names>G</given-names> <surname>Griffiths</surname></string-name> and <string-name name-style="western" hwp:sortable="Marsh M"><given-names>M</given-names> <surname>Marsh</surname></string-name>. <article-title hwp:id="article-title-43">Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells</article-title>. <source hwp:id="source-42">The Journal of experimental medicine</source>, <volume>173</volume> (<issue>3</issue>):<fpage>575</fpage>–<lpage>587</lpage>, March <year>1991</year>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Pelchen-Matthews A"><given-names>A</given-names> <surname>Pelchen-Matthews</surname></string-name>, <string-name name-style="western" hwp:sortable="Boulet I"><given-names>I</given-names> <surname>Boulet</surname></string-name>, <string-name name-style="western" hwp:sortable="Littman D R"><given-names>D R</given-names> <surname>Littman</surname></string-name>, <string-name name-style="western" hwp:sortable="Fagard R"><given-names>R</given-names> <surname>Fagard</surname></string-name>, and <string-name name-style="western" hwp:sortable="Marsh M"><given-names>M</given-names> <surname>Marsh</surname></string-name>. <article-title hwp:id="article-title-44">The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits</article-title>. <source hwp:id="source-43">J Cell Biol</source>, <volume>117</volume>(<issue>2</issue>):<fpage>279</fpage>–<lpage>290</lpage>, April <year>1992</year>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1 xref-ref-44-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Pelchen-Matthews A"><given-names>A</given-names> <surname>Pelchen-Matthews</surname></string-name>, <string-name name-style="western" hwp:sortable="Clapham P"><given-names>P</given-names> <surname>Clapham</surname></string-name>, and <string-name name-style="western" hwp:sortable="Marsh M"><given-names>M</given-names> <surname>Marsh</surname></string-name>. <article-title hwp:id="article-title-45">Role of CD4 endocytosis in human immunodeficiency virus infection</article-title>. <source hwp:id="source-44">J Virol</source>, <volume>69</volume>(<issue>12</issue>): <fpage>8164</fpage>–<lpage>8168</lpage>, December <year>1995</year>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Permanyer Marc"><given-names>Marc</given-names> <surname>Permanyer</surname></string-name> <string-name name-style="western" hwp:sortable="Ballana Ester"><given-names>Ester</given-names> <surname>Ballana</surname></string-name> and <string-name name-style="western" hwp:sortable="Esté José A"><given-names>José A</given-names> <surname>Esté</surname></string-name>. <article-title hwp:id="article-title-46">Endocytosis of HIV: anything goes</article-title>. <source hwp:id="source-45">Trends Microbiol</source>, <volume>18</volume>(<issue>12</issue>):<fpage>543</fpage>–<lpage>551</lpage>, December <year>2010</year>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Pineda Mario Javier"><given-names>Mario Javier</given-names> <surname>Pineda</surname></string-name>, <string-name name-style="western" hwp:sortable="Orton Brannon R"><given-names>Brannon R</given-names> <surname>Orton</surname></string-name>, and <string-name name-style="western" hwp:sortable="Overbaugh Julie"><given-names>Julie</given-names> <surname>Overbaugh</surname></string-name>. <article-title hwp:id="article-title-47">A TRIM5<italic toggle="yes">α</italic>-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry</article-title>. <source hwp:id="source-46">Virology</source>, <volume>363</volume>(<issue>2</issue>):<fpage>310</fpage>–<lpage>318</lpage>, July <year>2007</year>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Pitcher C"><given-names>C</given-names> <surname>Pitcher</surname></string-name>, <string-name name-style="western" hwp:sortable="Honing S"><given-names>S</given-names> <surname>Honing</surname></string-name>, <string-name name-style="western" hwp:sortable="Fingerhut A"><given-names>A</given-names> <surname>Fingerhut</surname></string-name>, <string-name name-style="western" hwp:sortable="Bowers K"><given-names>K</given-names> <surname>Bowers</surname></string-name>, and <string-name name-style="western" hwp:sortable="Marsh M"><given-names>M</given-names> <surname>Marsh</surname></string-name>. <article-title hwp:id="article-title-48">Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation</article-title>. <source hwp:id="source-47">Mol Biol Cell</source>, <volume>10</volume>(<issue>3</issue>):<fpage>677</fpage>–<lpage>691</lpage>, March <year>1999</year>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1 xref-ref-48-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Platt E J"><given-names>E J</given-names> <surname>Platt</surname></string-name>, <string-name name-style="western" hwp:sortable="Kozak S L"><given-names>S L</given-names> <surname>Kozak</surname></string-name>, and <string-name name-style="western" hwp:sortable="Kabat D"><given-names>D</given-names> <surname>Kabat</surname></string-name>. <article-title hwp:id="article-title-49">Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type</article-title> <source hwp:id="source-48">AIDS research and human retroviruses</source>, <volume>16</volume>(<issue>9</issue>): <fpage>871</fpage>–<lpage>882</lpage>, June <year>2000</year>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1 xref-ref-49-2 xref-ref-49-3 xref-ref-49-4 xref-ref-49-5 xref-ref-49-6"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Reuter Sandra"><given-names>Sandra</given-names> <surname>Reuter</surname></string-name>, <string-name name-style="western" hwp:sortable="Kaumanns Patrick"><given-names>Patrick</given-names> <surname>Kaumanns</surname></string-name>, <string-name name-style="western" hwp:sortable="Buschhorn Sabine B"><given-names>Sabine B</given-names> <surname>Buschhorn</surname></string-name>, and <string-name name-style="western" hwp:sortable="Dittmar Matthias T"><given-names>Matthias T</given-names> <surname>Dittmar</surname></string-name>. <article-title hwp:id="article-title-50">Role of HIV-2 envelope in Lv2-mediated restriction</article-title>. <source hwp:id="source-49">Virology</source>, <volume>332</volume>(<issue>1</issue>):<fpage>347</fpage>–<lpage>358</lpage>, February <year>2005</year>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><citation publication-type="book" citation-type="book" ref:id="177808v1.50" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Rodgers William"><given-names>William</given-names> <surname>Rodgers</surname></string-name>. <chapter-title>Making membranes green: construction and characterization of GFP-fusion proteins targeted to discrete plasma membrane domains</chapter-title>. <source hwp:id="source-50">Technical report Molecular Immunogenetics Program</source>, <publisher-name>Oklahoma Medical Research Foundation</publisher-name>, <publisher-loc>Oklahoma City 73104, USA</publisher-loc>. william-rodgers@omrf.ouhsc.edu, May <year>2002</year>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Sayah David M"><given-names>David M</given-names> <surname>Sayah</surname></string-name>, <string-name name-style="western" hwp:sortable="Sokolskaja Elena"><given-names>Elena</given-names> <surname>Sokolskaja</surname></string-name>, <string-name name-style="western" hwp:sortable="Berthoux Lionel"><given-names>Lionel</given-names> <surname>Berthoux</surname></string-name>, and <string-name name-style="western" hwp:sortable="Luban Jeremy"><given-names>Jeremy</given-names> <surname>Luban</surname></string-name>. <article-title hwp:id="article-title-51">Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1</article-title>. <source hwp:id="source-51">Nature</source>, <volume>430</volume> (<issue>6999</issue>):<fpage>569</fpage>–<lpage>573</lpage>, July <year>2004</year>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1 xref-ref-52-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Scherer William F"><given-names>William F</given-names> <surname>Scherer</surname></string-name>, <string-name name-style="western" hwp:sortable="Syverton Jerome T"><given-names>Jerome T</given-names> <surname>Syverton</surname></string-name>, and <string-name name-style="western" hwp:sortable="Gey George O"><given-names>George O</given-names> <surname>Gey</surname></string-name>. <article-title hwp:id="article-title-52">Studies on the propagation in vitro of poliomyelitis viruses: IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain hela) derived from an epidermoid carcinoma of the cervix</article-title>. <source hwp:id="source-52">Journal of Experimental Medicine</source>, <volume>97</volume>(<issue>5</issue>):<fpage>695</fpage>–<lpage>710</lpage>, May <year>1953</year>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1 xref-ref-53-2 xref-ref-53-3 xref-ref-53-4 xref-ref-53-5 xref-ref-53-6 xref-ref-53-7 xref-ref-53-8 xref-ref-53-9 xref-ref-53-10 xref-ref-53-11 xref-ref-53-12"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Schmitz C"><given-names>C</given-names> <surname>Schmitz</surname></string-name>, <string-name name-style="western" hwp:sortable="Marchant D"><given-names>D</given-names> <surname>Marchant</surname></string-name>, <string-name name-style="western" hwp:sortable="Neil SJD"><given-names>SJD</given-names> <surname>Neil</surname></string-name>, <string-name name-style="western" hwp:sortable="Aubin K"><given-names>K</given-names> <surname>Aubin</surname></string-name>, <string-name name-style="western" hwp:sortable="Reuter S"><given-names>S</given-names> <surname>Reuter</surname></string-name>, <string-name name-style="western" hwp:sortable="Dittmar M T"><given-names>M T</given-names> <surname>Dittmar</surname></string-name>, and <string-name name-style="western" hwp:sortable="McKnight A"><given-names>A</given-names> <surname>McKnight</surname></string-name>. <article-title hwp:id="article-title-53">Lv2, a novel postentry restriction is mediated by both capsid and envelope</article-title>. <source hwp:id="source-53">J Virol</source>, <volume>78</volume>(<issue>4</issue>):<fpage>2006</fpage>– <lpage>2016</lpage>, February <year>2004</year>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1 xref-ref-54-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Soda Yasushi"><given-names>Yasushi</given-names> <surname>Soda</surname></string-name>, <string-name name-style="western" hwp:sortable="Shimizu Nobuaki"><given-names>Nobuaki</given-names> <surname>Shimizu</surname></string-name>, <string-name name-style="western" hwp:sortable="Jinno Atsushi"><given-names>Atsushi</given-names> <surname>Jinno</surname></string-name>, <string-name name-style="western" hwp:sortable="Liu Hui Yu"><given-names>Hui Yu</given-names> <surname>Liu</surname></string-name>, <string-name name-style="western" hwp:sortable="Kanbe Katsuaki"><given-names>Katsuaki</given-names> <surname>Kanbe</surname></string-name>, <string-name name-style="western" hwp:sortable="Kitamura Toshio"><given-names>Toshio</given-names> <surname>Kitamura</surname></string-name>, and <string-name name-style="western" hwp:sortable="Hoshino Hiroo"><given-names>Hiroo</given-names> <surname>Hoshino</surname></string-name>. <article-title hwp:id="article-title-54">Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line</article-title>. <source hwp:id="source-54">Biochemical and Biophysical Research Communications</source>, <volume>258</volume>(<issue>2</issue>):<fpage>313</fpage>–<lpage>321</lpage>, May <year>1999</year>.</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1 xref-ref-55-2"><citation publication-type="other" citation-type="journal" ref:id="177808v1.55" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Soneoka Y"><given-names>Y</given-names> <surname>Soneoka</surname></string-name>, <string-name name-style="western" hwp:sortable="Cannon P M"><given-names>P M</given-names> <surname>Cannon</surname></string-name>, <string-name name-style="western" hwp:sortable="Ramsdale E E"><given-names>E E</given-names> <surname>Ramsdale</surname></string-name>, <string-name name-style="western" hwp:sortable="Griffiths J C"><given-names>J C</given-names> <surname>Griffiths</surname></string-name>, <string-name name-style="western" hwp:sortable="Romano G"><given-names>G</given-names> <surname>Romano</surname></string-name>, <string-name name-style="western" hwp:sortable="Kingsman S M"><given-names>S M</given-names> <surname>Kingsman</surname></string-name>, and <string-name name-style="western" hwp:sortable="Kingsman A J"><given-names>A J</given-names> <surname>Kingsman</surname></string-name>. <article-title hwp:id="article-title-55">A transient three-plasmid expression system for the production of high titer retroviral vectors</article-title>. <volume>23</volume>(<issue>4</issue>):<fpage>628</fpage>–<lpage>633</lpage>, <year>1995</year>.</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Sorin Masha"><given-names>Masha</given-names> <surname>Sorin</surname></string-name> and <string-name name-style="western" hwp:sortable="Kalpana Ganjam V"><given-names>Ganjam V</given-names> <surname>Kalpana</surname></string-name>. <article-title hwp:id="article-title-56">Dynamics of virus-host interplay in HIV-1 replication</article-title>. <source hwp:id="source-55">Current HIV research</source>, <volume>4</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>130</lpage>, April <year>2006</year>.</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1 xref-ref-57-2 xref-ref-57-3 xref-ref-57-4 xref-ref-57-5 xref-ref-57-6"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Stremlau Matthew"><given-names>Matthew</given-names> <surname>Stremlau</surname></string-name>, <string-name name-style="western" hwp:sortable="Owens Christopher M"><given-names>Christopher M</given-names> <surname>Owens</surname></string-name>, <string-name name-style="western" hwp:sortable="Perron Michel J"><given-names>Michel J</given-names> <surname>Perron</surname></string-name>, <string-name name-style="western" hwp:sortable="Kiessling Michael"><given-names>Michael</given-names> <surname>Kiessling</surname></string-name> <string-name name-style="western" hwp:sortable="Autissier Patrick"><given-names>Patrick</given-names> <surname>Autissier</surname></string-name> and <string-name name-style="western" hwp:sortable="Sodroski Joseph"><given-names>Joseph</given-names> <surname>Sodroski</surname></string-name>. <article-title hwp:id="article-title-57">The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys</article-title>. <source hwp:id="source-56">Nature</source>, <volume>427</volume>(<issue>6977</issue>):<fpage>848</fpage>–<lpage>853</lpage>, February <year>2004</year>.</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Superti F"><given-names>F</given-names> <surname>Superti</surname></string-name>, <string-name name-style="western" hwp:sortable="Seganti L"><given-names>L</given-names> <surname>Seganti</surname></string-name>, <string-name name-style="western" hwp:sortable="Ruggeri F M"><given-names>F M</given-names> <surname>Ruggeri</surname></string-name>, <string-name name-style="western" hwp:sortable="Tinari A"><given-names>A</given-names> <surname>Tinari</surname></string-name>, <string-name name-style="western" hwp:sortable="Donelli G"><given-names>G</given-names> <surname>Donelli</surname></string-name>, and <string-name name-style="western" hwp:sortable="Orsi N"><given-names>N</given-names> <surname>Orsi</surname></string-name>. <article-title hwp:id="article-title-58">Entry pathway of vesicular stomatitis virus into different host cells</article-title>. <source hwp:id="source-57">The Journal of general virology</source>, <volume>68</volume> (Pt 2) (<issue>2</issue>):<fpage>387</fpage>–<lpage>399</lpage>, February <year>1987</year>.</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Towers G"><given-names>G</given-names> <surname>Towers</surname></string-name>, <string-name name-style="western" hwp:sortable="Bock M"><given-names>M</given-names> <surname>Bock</surname></string-name>, <string-name name-style="western" hwp:sortable="Martin S"><given-names>S</given-names> <surname>Martin</surname></string-name>, <string-name name-style="western" hwp:sortable="Takeuchi Y"><given-names>Y</given-names> <surname>Takeuchi</surname></string-name>, <string-name name-style="western" hwp:sortable="Stoye J P"><given-names>J P</given-names> <surname>Stoye</surname></string-name>, and <string-name name-style="western" hwp:sortable="Danos O"><given-names>O</given-names> <surname>Danos</surname></string-name>. <article-title hwp:id="article-title-59">A conserved mechanism of retrovirus restriction in mammals</article-title>. <source hwp:id="source-58">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>97</volume>(<issue>22</issue>):<fpage>12295</fpage>–<lpage>12299</lpage>, October <year>2000</year>.</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Towers Greg"><given-names>Greg</given-names> <surname>Towers</surname></string-name>, <string-name name-style="western" hwp:sortable="Collins Mary"><given-names>Mary</given-names> <surname>Collins</surname></string-name>, and <string-name name-style="western" hwp:sortable="Takeuchi Yasuhiro"><given-names>Yasuhiro</given-names> <surname>Takeuchi</surname></string-name>. <article-title hwp:id="article-title-60">Abrogation of Ref1 retrovirus restriction in human cells</article-title>. <source hwp:id="source-59">Journal of Virology</source>, <volume>76</volume>(<issue>5</issue>):<fpage>2548</fpage>–<lpage>2550</lpage>, March <year>2002</year>.</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Tan H Van"><given-names>H Van</given-names> <surname>Tan</surname></string-name>, <string-name name-style="western" hwp:sortable="Allée G"><given-names>G</given-names> <surname>Allée</surname></string-name>, <string-name name-style="western" hwp:sortable="Benes C"><given-names>C</given-names> <surname>Benes</surname></string-name>, <string-name name-style="western" hwp:sortable="Barnier J V"><given-names>J V</given-names> <surname>Barnier</surname></string-name>, <string-name name-style="western" hwp:sortable="Vincent J D"><given-names>J D</given-names> <surname>Vincent</surname></string-name>, and <string-name name-style="western" hwp:sortable="Fagard R"><given-names>R</given-names> <surname>Fagard</surname></string-name>. <article-title hwp:id="article-title-61">Expression of a novel form of the p56lck protooncogene in rat cerebellar granular neurons</article-title>. <source hwp:id="source-60">Journal of neurochemistry</source>, <volume>67</volume>(<issue>6</issue>):<fpage>2306</fpage>–<lpage>2315</lpage>, December <year>1996</year>.</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Walter B L"><given-names>B L</given-names> <surname>Walter</surname></string-name>, <string-name name-style="western" hwp:sortable="Wehrly K"><given-names>K</given-names> <surname>Wehrly</surname></string-name> <string-name name-style="western" hwp:sortable="Swanstrom R"><given-names>R</given-names> <surname>Swanstrom</surname></string-name>, <string-name name-style="western" hwp:sortable="Platt E"><given-names>E</given-names> <surname>Platt</surname></string-name>, <string-name name-style="western" hwp:sortable="Kabat D"><given-names>D</given-names> <surname>Kabat</surname></string-name>, and <string-name name-style="western" hwp:sortable="Chesebro B"><given-names>B</given-names> <surname>Chesebro</surname></string-name>. <article-title hwp:id="article-title-62">Role of Low CD4 Levels in the Influence of Human Immunodeficiency Virus Type 1 Envelope V1 and V2 Regions on Entry and Spread in Macrophages</article-title>. <source hwp:id="source-61">J Virol</source>, <volume>79</volume>(<issue>8</issue>):<fpage>4828</fpage>–<lpage>4837</lpage>, March <year>2005</year>.</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Wilson Sam J"><given-names>Sam J</given-names> <surname>Wilson</surname></string-name>, <string-name name-style="western" hwp:sortable="Webb Benjamin L J"><given-names>Benjamin L J</given-names> <surname>Webb</surname></string-name>, <string-name name-style="western" hwp:sortable="Ylinen Laura M J"><given-names>Laura M J</given-names> <surname>Ylinen</surname></string-name>, <string-name name-style="western" hwp:sortable="Verschoor Ernst"><given-names>Ernst</given-names> <surname>Verschoor</surname></string-name>, <string-name name-style="western" hwp:sortable="Heeney Jonathan L"><given-names>Jonathan L</given-names> <surname>Heeney</surname></string-name>, and <string-name name-style="western" hwp:sortable="Towers Greg J"><given-names>Greg J</given-names> <surname>Towers</surname></string-name>. <article-title hwp:id="article-title-63">Independent evolution of an antiviral TRIMCyp in rhesus macaques</article-title>. <source hwp:id="source-62">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>105</volume>(<issue>9</issue>):<fpage>3557</fpage>–<lpage>3562</lpage>, March <year>2008</year>.</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1 xref-ref-64-2 xref-ref-64-3"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Yap M W"><given-names>M W</given-names> <surname>Yap</surname></string-name>, <string-name name-style="western" hwp:sortable="Dodding M P"><given-names>M P</given-names> <surname>Dodding</surname></string-name>, and <string-name name-style="western" hwp:sortable="Stoye J P"><given-names>J P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-64">Trim-Cyclophilin A Fusion Proteins Can Restrict Human Immunodeficiency Virus Type 1 Infection at Two Distinct Phases in the Viral Life Cycle</article-title>. <source hwp:id="source-63">Journal of Virology</source>, <volume>80</volume>(<issue>8</issue>):<fpage>4061</fpage>–<lpage>4067</lpage>, March <year>2006</year>.</citation></ref><ref id="c65" hwp:id="ref-65" hwp:rev-id="xref-ref-65-1 xref-ref-65-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Yap Melvyn W"><given-names>Melvyn W</given-names> <surname>Yap</surname></string-name>, <string-name name-style="western" hwp:sortable="Nisole Sébastien"><given-names>Sébastien</given-names> <surname>Nisole</surname></string-name>, <string-name name-style="western" hwp:sortable="Lynch Clare"><given-names>Clare</given-names> <surname>Lynch</surname></string-name>, and <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-65">Trim5alpha protein restricts both HIV-1 and murine leukemia virus</article-title>. <source hwp:id="source-64">Proceedings of the National Academy of Sciences of the United States of America</source>, <volume>101</volume>(<issue>29</issue>): <fpage>10786</fpage>–<lpage>10791</lpage>, July <year>2004</year>.</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1 xref-ref-66-2"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Yap Melvyn W"><given-names>Melvyn W</given-names> <surname>Yap</surname></string-name>, <string-name name-style="western" hwp:sortable="Mortuza Gulnahar B"><given-names>Gulnahar B</given-names> <surname>Mortuza</surname></string-name>, <string-name name-style="western" hwp:sortable="Taylor Ian A"><given-names>Ian A</given-names> <surname>Taylor</surname></string-name>, and <string-name name-style="western" hwp:sortable="Stoye Jonathan P"><given-names>Jonathan P</given-names> <surname>Stoye</surname></string-name>. <article-title hwp:id="article-title-66">The design of artificial retroviral restriction factors</article-title>. <source hwp:id="source-65">Virology</source>, <volume>365</volume>(<issue>2</issue>):<fpage>302</fpage>–<lpage>314</lpage>, September <year>2007</year>.</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Ylinen Laura M J"><given-names>Laura M J</given-names> <surname>Ylinen</surname></string-name>, <string-name name-style="western" hwp:sortable="Keckesova Zuzana"><given-names>Zuzana</given-names> <surname>Keckesova</surname></string-name> <string-name name-style="western" hwp:sortable="Wilson Sam J"><given-names>Sam J</given-names> <surname>Wilson</surname></string-name>, <string-name name-style="western" hwp:sortable="Ranasinghe Srinika"><given-names>Srinika</given-names> <surname>Ranasinghe</surname></string-name> and <string-name name-style="western" hwp:sortable="Towers Greg J"><given-names>Greg J</given-names> <surname>Towers</surname></string-name>. <article-title hwp:id="article-title-67">Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles</article-title>. <source hwp:id="source-66">Journal of Virology</source>, <volume>79</volume>(<issue>18</issue>):<fpage>11580</fpage>–<lpage>11587</lpage>, September <year>2005</year>.</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1"><citation publication-type="journal" citation-type="journal" ref:id="177808v1.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Yousefi S"><given-names>S</given-names> <surname>Yousefi</surname></string-name> <string-name name-style="western" hwp:sortable="Ma X Z"><given-names>X Z</given-names> <surname>Ma</surname></string-name>, <string-name name-style="western" hwp:sortable="Singla R"><given-names>R</given-names> <surname>Singla</surname></string-name> <string-name name-style="western" hwp:sortable="Zhou Y C"><given-names>Y C</given-names> <surname>Zhou</surname></string-name>, <string-name name-style="western" hwp:sortable="Sakac D"><given-names>D</given-names> <surname>Sakac</surname></string-name> <string-name name-style="western" hwp:sortable="Bali M"><given-names>M</given-names> <surname>Bali</surname></string-name> <string-name name-style="western" hwp:sortable="Liu Y"><given-names>Y</given-names> <surname>Liu</surname></string-name> <string-name name-style="western" hwp:sortable="Sahai B M"><given-names>B M</given-names> <surname>Sahai</surname></string-name>, and <string-name name-style="western" hwp:sortable="Branch D R"><given-names>D R</given-names> <surname>Branch</surname></string-name>. <article-title hwp:id="article-title-68">HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity</article-title>. <source hwp:id="source-67">Clinical and experimental immunology</source>, <volume>133</volume> (<issue>1</issue>):<fpage>78</fpage>–<lpage>90</lpage>, July <year>2003</year>.</citation></ref></ref-list></back></article>
